rfhg_9603.1

Basic information about the TSS

---

TSS ID: rfhg_9603.1 Species: human Chr: chr1		Start: 93908734 End: 93908734 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000467772.1:-56 GeneID: 2730 HGNC/MGI_ID: HGNC:4312 UniProt_ID: Nearer transcript ids and distances: ENST00000462183.1:-190 CR541833:-429 CU692038:-430 KJ891251:-430 view more...

Gene_name: GCLM Gene_symbol: GCLM Gene_synonyms: Gene_source: HGNC:4312

TATA-Box annotation

---

Distance to TSS:	696
Nearest PromoterID:	NM_002061
Entrez ID:	2730
Nearest Unigene:	Hs.315562
Nearest Refseq:	NM_002061
Nearest Ensembl:	ENSG00000023909
Gene Name:	GCLM
Gene Alias:	GLCLR
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GCLM p2@GCLM p3@GCLM p4@GCLM p5@GCLM p6@GCLM p7@GCLM p8@GCLM p9@GCLM
Sample		p1@GCLM	p2@GCLM	p3@GCLM	p4@GCLM	p5@GCLM	p6@GCLM	p7@GCLM	p8@GCLM	p9@GCLM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.91	6.62	0.39	0.39	0.00	0.58	0.00	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.10	3.84	0.20	0.40	0.61	0.81	0.20	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.68	4.44	0.58	0.19	0.39	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	3.33	0.62	0.21	0.21	0.42	0.42	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.87	4.05	0.45	0.45	0.22	0.22	0.67	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.92	3.68	0.19	0.00	0.78	0.39	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.77	4.79	1.09	0.00	0.44	0.65	0.65	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.66	4.84	0.97	0.24	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.69	4.70	0.85	0.00	0.21	0.64	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	6.96	0.58	0.00	1.16	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.70	4.45	1.21	0.00	0.40	1.21	0.00	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.13	6.10	2.85	0.41	0.00	0.41	1.22	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.41	6.93	0.81	0.48	0.81	0.32	0.32	1.13	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.01	4.96	0.90	0.75	0.30	0.15	0.45	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.71	3.51	0.66	0.66	1.10	0.88	0.88	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.55	4.53	0.75	0.75	0.50	0.75	0.25	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.55	3.49	0.66	0.87	0.44	0.87	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.91	6.75	1.27	0.42	0.84	1.27	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	7.46	1.60	0.53	0.00	1.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.52	3.91	0.15	0.45	0.15	0.45	0.45	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	7.22	4.01	0.40	0.80	0.27	0.13	0.00	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.39	3.28	0.52	0.35	0.35	0.17	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	6.59	3.75	0.78	0.39	0.00	0.65	0.00	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.52	4.13	0.97	0.73	0.24	0.73	0.49	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.22	5.42	0.26	0.00	1.03	0.52	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	1.27	0.32	0.32	0.32	0.95	0.63	0.95	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	5.49	0.00	0.00	0.00	0.00	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	5.89	1.18	0.24	0.00	0.71	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.75	5.49	0.32	0.65	0.48	0.00	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.77	5.61	0.00	0.36	0.18	0.18	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	6.49	0.42	1.05	0.00	0.63	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.36	5.28	0.59	0.78	0.59	0.39	0.59	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.35	4.64	0.63	0.63	0.42	0.63	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.17	4.95	0.00	0.33	0.82	0.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.76	8.23	0.00	1.12	0.75	0.37	0.56	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.19	6.52	0.38	0.96	0.57	0.57	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.95	12.06	0.00	0.41	0.20	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.23	7.86	0.00	0.20	0.40	0.00	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	36.19	13.24	0.27	1.35	0.81	0.27	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.05	13.20	0.24	0.24	0.24	0.00	1.20	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.29	7.76	0.71	0.00	0.24	0.00	0.71	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	42.75	9.52	0.29	0.59	0.44	0.00	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	59.89	17.50	0.21	0.42	0.21	0.21	2.11	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	56.47	15.91	0.35	0.00	0.52	0.52	0.87	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	56.62	13.25	0.20	0.20	0.20	0.20	1.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.79	15.12	0.00	0.23	0.47	0.00	1.16	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	68.85	15.35	0.96	0.00	0.48	0.00	0.96	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	59.31	12.82	0.30	0.30	0.30	0.60	2.38	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	52.18	12.93	0.00	0.72	0.24	0.00	1.20	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.02	10.72	0.61	0.20	0.20	0.40	0.61	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.56	13.12	0.00	0.82	0.20	0.20	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	33.36	10.67	0.44	0.44	0.22	0.00	1.11	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.87	5.68	0.35	0.35	0.35	0.00	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.91	7.95	0.00	0.33	0.00	0.00	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	5.87	0.00	0.00	0.00	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.18	6.43	0.00	0.00	0.00	0.00	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.21	6.81	0.00	0.65	0.00	0.00	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.80	5.78	0.00	0.64	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	2.20	0.31	0.00	0.94	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	5.64	0.00	0.00	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.09	1.68	0.00	0.56	0.00	0.00	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	3.98	0.00	0.00	0.00	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.14	3.74	0.68	0.00	0.34	0.34	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.40	7.80	0.65	0.00	0.32	0.00	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.23	4.97	0.00	0.35	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	32.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	15.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	3.90	0.49	0.00	0.49	0.49	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	4.46	0.00	0.50	0.00	0.99	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.16	4.22	0.47	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.62	5.63	0.00	0.66	0.33	0.00	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.59	8.04	0.31	0.00	0.00	0.00	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	3.06	0.61	0.61	0.00	0.00	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	25.18	7.29	1.43	0.63	0.63	0.63	0.32	0.16	0.63
Adipocyte - breast, donor2	11327-117E4	17.97	6.74	1.60	0.96	0.48	0.64	0.16	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	32.06	10.43	1.02	0.25	0.13	0.76	0.38	0.25	1.15
Adipocyte - omental, donor2	11474-119C7	17.19	10.46	0.00	0.00	0.00	2.24	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.72	4.69	1.34	0.67	0.33	0.67	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.85	2.55	0.00	0.64	0.00	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	3.30	0.00	1.10	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	23.94	4.52	0.00	0.00	0.00	0.45	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.73	4.34	0.70	1.39	0.35	0.17	0.00	0.35	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	17.60	7.04	0.39	0.39	0.00	0.00	0.20	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	3.86	0.26	0.77	0.00	0.51	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	20.07	7.81	0.56	1.12	0.00	0.56	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	34.68	9.40	0.00	0.59	1.18	0.00	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.58	13.19	0.24	2.01	0.80	0.16	0.16	0.16	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	11.30	4.20	0.00	0.97	0.00	0.32	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	13.33	4.27	0.53	0.00	1.60	0.53	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	31.16	13.35	0.00	1.11	1.11	0.00	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	10.81	0.00	2.50	0.83	0.00	0.83	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	13.31	7.28	0.50	0.75	0.75	0.25	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.00	11.13	0.00	0.33	0.00	0.33	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.92	10.96	0.61	2.13	0.30	0.30	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.46	2.21	0.00	0.00	0.00	0.00	0.66	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	4.79	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	2.70	1.08	1.08	0.36	0.00	0.36	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	1.67	5.02	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.37	2.05	1.44	0.00	0.62	0.41	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	20.83	8.12	0.69	0.57	0.11	0.23	0.57	0.11	0.46
Anulus Pulposus Cell, donor2	11463-119B5	17.88	12.74	0.49	0.24	0.24	0.00	0.73	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	4.49	0.45	0.00	0.00	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	6.51	0.00	0.43	0.00	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.75	3.59	0.00	0.00	0.00	0.30	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	5.06	0.00	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	3.96	0.00	0.00	0.00	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.92	3.90	0.65	0.32	0.00	0.32	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.87	8.25	0.00	0.00	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	4.75	0.00	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	2.64	0.00	0.38	0.38	0.00	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.77	6.53	0.00	0.00	0.00	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	12.54	0.00	0.00	0.00	0.00	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.16	4.61	0.00	0.00	0.00	0.00	1.32	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	5.46	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	24.43	6.18	0.15	0.00	0.15	0.30	0.60	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	3.75	0.00	0.54	0.54	0.00	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	19.27	5.67	0.19	0.00	0.19	0.00	0.76	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.72	4.28	0.00	0.00	0.27	0.00	1.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.74	6.14	0.66	0.17	0.17	0.17	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	4.80	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	0.00	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	21.27	5.66	0.17	0.34	0.00	0.17	1.03	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.11	6.31	0.49	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.01	5.31	0.00	0.00	0.76	0.38	1.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	4.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	5.70	0.00	0.57	0.00	0.00	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.46	3.63	0.00	0.21	0.00	0.00	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.07	4.13	0.52	0.26	0.00	0.52	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	1.88	0.00	0.00	0.47	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.61	4.50	0.32	0.32	0.00	0.32	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	2.14	0.00	0.00	0.00	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	17.55	3.51	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.86	4.52	0.00	0.30	0.00	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	5.94	0.00	0.00	0.00	0.00	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	5.09	0.00	0.00	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.85	5.35	0.00	0.00	0.00	0.25	0.51	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	6.35	0.00	0.64	0.00	0.64	2.54	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.38	3.88	0.00	0.00	0.00	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.55	4.23	0.00	0.21	0.21	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.98	4.35	0.29	0.00	0.58	0.29	1.16	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	1.89	0.00	0.00	0.00	0.00	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.22	3.90	0.17	0.17	0.51	0.51	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	6.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	20.37	4.72	0.21	0.00	0.00	0.21	0.64	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	6.62	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	2.92	0.00	0.00	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.01	5.98	0.00	0.23	0.23	0.00	2.53	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.29	5.85	0.00	0.00	0.00	0.25	1.78	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.06	5.99	0.00	0.00	0.00	0.21	0.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.87	3.37	0.00	0.00	0.00	0.00	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	5.26	0.48	0.48	0.48	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	24.39	7.54	0.44	0.22	0.22	0.44	0.00	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	7.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.94	5.54	0.00	0.00	0.00	1.11	2.22	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.18	7.68	0.00	0.26	0.26	0.00	0.53	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	6.54	0.00	0.00	0.00	0.36	2.18	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	5.65	3.81	0.61	0.98	0.61	0.61	0.12	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	5.99	3.59	0.86	1.03	1.03	0.34	0.00	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	8.18	4.82	0.84	0.84	0.84	1.47	0.63	0.21	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	5.23	3.83	1.05	1.05	0.70	1.39	0.35	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	14.72	6.79	0.97	0.65	0.65	0.81	0.65	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	6.86	3.88	1.64	2.09	1.04	0.45	0.30	1.34	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1.61	5.96	4.13	5.16	1.83	3.21	0.23	1.38	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.75	5.89	5.01	4.38	3.76	3.13	0.25	1.50	2.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.28	6.37	3.19	5.23	3.41	1.59	0.00	1.37	1.48
Basophils, donor1	12241-129G9	2.88	1.05	0.00	0.26	0.00	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	2.89	4.33	1.44	1.80	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	1.47	1.62	0.44	0.29	0.15	0.29	0.29	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	9.70	1.51	0.22	0.00	0.00	0.22	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	3.20	0.46	0.46	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.08	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	10.19	1.46	0.21	0.42	0.00	0.00	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.82	2.76	0.23	0.00	0.23	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	49.13	10.44	0.36	0.18	0.00	0.54	0.36	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.52	2.58	3.09	3.40	1.55	1.44	0.10	0.93	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.73	9.78	1.40	5.36	0.93	1.63	0.00	0.93	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	5.12	0.96	1.60	0.64	0.00	1.28	0.32	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	2.23	1.67	0.19	0.19	0.37	0.56	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	3.29	0.88	0.00	0.00	0.22	0.22	0.22	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	10.19	3.11	1.70	1.70	0.57	0.28	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	22.37	4.93	3.41	1.90	1.52	2.65	0.00	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	17.09	1.97	1.64	1.31	0.99	0.99	0.33	0.99	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	47.12	3.32	0.14	0.14	0.29	0.00	0.43	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	67.89	6.64	0.30	0.00	0.30	0.00	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	30.32	1.90	0.24	0.24	0.00	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	66.29	4.52	0.17	0.00	0.17	0.17	0.67	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	149.05	2.76	0.55	0.00	0.00	0.00	1.10	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	137.35	4.96	0.50	0.00	0.00	0.00	0.74	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	253.56	7.83	0.39	0.00	0.00	0.00	4.11	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	251.76	5.88	0.18	0.00	0.18	0.18	4.10	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	274.21	11.32	0.22	0.00	0.00	0.00	5.44	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	63.45	6.32	0.00	0.23	0.00	0.00	0.70	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	132.01	4.75	1.06	0.53	0.00	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	108.72	7.77	0.00	0.00	0.00	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	68.57	5.35	0.15	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	175.00	10.18	0.00	0.00	0.00	0.20	2.00	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	123.25	8.74	0.00	0.21	0.21	0.00	1.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	88.08	5.49	0.00	0.23	0.00	0.00	1.37	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	124.86	5.20	0.00	0.45	0.23	0.68	0.90	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	61.54	4.80	0.00	0.00	0.00	0.00	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	189.91	4.84	0.27	0.27	0.00	0.00	3.50	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	242.50	10.29	0.35	0.00	0.35	0.17	9.25	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	212.51	8.00	0.00	0.00	0.00	0.00	5.05	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	132.09	4.04	0.37	0.18	0.18	0.18	0.73	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	258.21	4.93	0.00	0.00	0.00	0.00	4.23	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	176.37	5.26	0.00	0.00	0.00	0.00	2.63	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	280.39	9.59	0.17	0.17	0.00	0.17	5.75	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	234.53	5.95	0.37	0.00	0.00	0.74	5.58	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	280.21	8.41	0.22	0.00	0.00	0.00	6.90	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	159.70	5.73	0.41	0.00	0.00	0.41	2.87	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	166.66	3.01	0.00	0.00	0.00	0.00	2.09	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	118.32	1.62	0.23	0.00	0.00	0.00	2.55	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.65	0.22	0.00	0.22	0.22	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.23	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.22	0.22	0.65	0.22	0.00	0.22	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	1.40	0.78	0.00	0.16	0.16	0.00	0.00	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	1.05	0.87	0.17	0.17	0.00	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.01	0.67	0.22	0.00	0.22	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.26	0.77	0.00	0.51	0.26	0.26	0.00	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.22	0.44	0.00	0.44	0.22	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.63	0.84	0.63	0.00	0.42	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	2.03	4.06	0.00	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	1.36	2.71	1.36	2.03	1.36	0.68	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	2.07	2.07	2.07	2.07	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1.60	2.13	2.67	0.00	0.53	1.60	0.00	2.13	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	1.07	1.61	2.14	2.68	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.11	0.70	3.51	2.81	0.70	0.00	0.00	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	2.35	5.49	0.78	0.78	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	0.00	3.95	2.64	0.00	0.00	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	2.47	0.00	0.00	1.64	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	0.00	1.45	1.45	0.00	0.00	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	1.01	1.01	1.01	0.50	2.52	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	325.27	27.07	0.81	0.00	0.81	0.00	4.44	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	276.45	20.37	0.80	0.00	0.80	0.00	3.20	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	4.02	2.01	1.00	1.00	0.00	2.01	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	10.67	2.25	0.00	0.56	0.00	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	8.27	2.63	1.13	3.01	0.75	1.50	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	7.44	3.38	1.35	0.45	0.45	0.45	0.00	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	0.36	2.14	2.50	1.07	2.50	3.93	0.00	1.43	0.71
CD4+ T Cells, donor2	11306-117C1	3.06	2.45	3.67	0.61	0.00	1.84	0.00	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	0.91	1.52	2.44	0.61	0.91	3.66	0.00	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.77	2.81	3.57	4.34	1.02	1.79	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.80	4.72	2.47	2.92	0.67	2.70	0.45	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	2.87	2.30	3.16	2.01	2.59	0.86	0.00	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	0.95	3.32	0.95	0.00	1.42	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	0.00	2.81	0.70	0.70	2.81	0.00	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	3.30	3.30	0.00	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.75	3.03	3.03	2.46	1.30	1.88	0.14	1.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2.03	4.07	3.05	2.03	1.53	1.86	0.17	0.34	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	4.03	3.87	2.74	2.42	1.45	1.13	0.48	0.32	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	1.34	2.24	0.45	0.00	1.79	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.40	1.40	3.49	2.45	1.05	2.10	0.00	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	2.64	1.32	1.76	1.32	2.20	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.53	2.11	5.06	4.64	0.00	0.84	0.00	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.49	5.40	4.57	4.36	2.08	1.45	0.00	1.25	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1.67	7.68	3.34	5.01	2.34	1.34	0.00	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.54	0.54	3.81	0.27	0.54	1.90	0.27	0.54	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	3.75	0.54	1.07	4.29	0.00	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	3.59	0.00	3.59	3.59	0.00	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	3.71	7.42	6.12	4.64	3.52	2.23	0.19	2.41	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	7.15	8.66	4.77	5.42	3.68	2.60	0.22	0.87	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	8.41	15.76	6.09	7.57	2.10	2.52	0.63	1.05	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.02	2.02	3.03	1.52	1.01	2.02	0.51	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.87	3.03	3.90	0.87	0.43	3.03	0.00	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.31	3.49	3.49	2.18	0.87	2.61	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.49	2.47	5.94	3.46	1.98	2.97	0.00	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	7.39	13.85	1.85	2.77	0.92	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	4.19	4.19	16.75	4.19	1.40	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1.94	5.54	5.54	2.49	2.22	3.60	0.00	1.66	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.98	2.94	6.38	2.70	2.21	2.94	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3.08	1.54	12.32	3.08	1.54	4.62	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.51	5.37	10.03	6.45	0.36	4.30	0.00	2.86	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	6.92	5.54	4.15	6.92	1.38	0.00	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	1.31	7.86	1.96	1.31	0.65	4.26	0.33	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	1.13	4.13	3.75	1.88	0.38	3.75	0.00	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	2.78	5.30	2.52	1.77	0.76	3.03	0.00	1.01	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.06	2.52	1.15	0.69	0.00	1.38	0.00	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.12	2.40	2.88	0.48	0.24	1.44	0.24	0.48	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	3.01	1.37	1.37	0.27	1.09	0.00	0.55	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.50	0.90	1.80	0.30	0.90	0.60	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	2.64	2.88	0.48	0.00	1.20	0.00	0.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.18	1.59	1.82	0.45	0.45	1.36	0.00	0.68	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.82	2.39	1.74	0.22	0.65	2.82	0.00	0.43	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.16	2.63	2.37	0.00	0.53	2.11	0.00	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.28	1.41	2.58	0.47	0.70	1.88	0.00	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.91	1.21	0.91	0.30	0.60	1.21	0.00	0.60	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.45	0.58	1.16	2.91	0.87	1.45	0.00	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.80	1.60	2.40	0.00	1.33	0.80	0.00	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.19	1.31	0.88	1.31	0.88	0.88	0.00	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.37	1.37	0.46	0.00	0.46	1.37	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.24	4.48	0.75	0.00	0.75	2.24	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.88	2.52	1.44	0.00	0.72	1.08	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.16	1.44	1.73	1.15	0.86	2.59	0.29	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.83	2.12	1.89	0.71	0.00	1.41	0.00	0.24	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.49	1.58	2.85	0.63	0.63	0.95	0.00	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.38	4.00	2.77	0.31	0.00	0.92	0.00	0.62	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.89	0.96	1.60	0.96	0.32	2.24	0.32	0.32	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.53	1.91	0.38	0.38	0.00	1.53	0.00	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.39	1.58	1.58	0.00	0.39	3.15	0.00	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	1.51	1.51	0.00	1.51	3.03	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.00	1.61	0.80	0.80	0.00	1.61	0.00	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1.40	1.40	2.10	0.70	1.40	4.20	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	1.00	3.01	1.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	29.24	14.62	0.00	0.00	0.00	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	17.29	4.45	0.00	0.99	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	16.21	6.63	1.26	0.84	0.63	0.42	0.42	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	135.20	45.41	0.35	0.69	0.35	0.00	2.08	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	61.12	15.99	0.00	0.00	0.36	0.00	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	79.76	32.77	0.57	0.57	0.68	0.34	2.73	0.46	0.34
Chondrocyte - re diff, donor2	11339-117F7	57.30	12.53	0.90	0.00	0.00	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.84	10.92	1.21	0.40	0.40	1.21	2.02	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	14.00	3.67	0.92	0.80	0.80	1.26	0.46	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	14.11	5.34	1.28	1.07	0.21	0.21	0.64	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	8.14	3.89	0.62	0.53	0.27	0.53	0.53	0.18	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	5.32	2.57	2.66	1.01	0.92	0.55	0.09	0.92	0.18
Corneal Epithelial Cells, donor1	11526-119I5	10.54	2.20	0.44	0.00	0.00	0.44	0.00	0.88	0.22
Corneal Epithelial Cells, donor2	11606-120I4	3.41	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	2.30	0.00	0.00	0.26	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	33.51	3.14	0.33	0.99	0.17	0.66	0.00	0.50	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.44	3.78	2.21	0.63	0.00	0.63	0.32	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.74	2.38	0.76	0.86	0.32	0.32	0.43	0.76	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.34	1.02	0.34	0.68	0.00	1.71	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.65	0.65	0.00	0.00	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	0.48	0.48	0.97	0.00	2.42	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	44.86	5.50	0.00	0.00	0.00	0.00	1.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	18.19	1.76	0.00	0.00	0.00	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.06	2.26	0.00	0.00	0.00	0.28	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	19.66	5.50	0.00	0.00	0.00	0.39	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.65	4.36	0.00	0.00	0.58	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	41.64	6.35	0.71	0.00	0.00	0.71	0.71	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	26.82	4.03	0.00	0.00	0.00	0.00	0.88	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.05	3.77	0.44	0.89	0.00	0.00	0.89	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.52	3.35	0.30	0.30	0.00	0.00	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.69	3.66	0.56	1.13	0.00	0.28	1.13	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	23.47	1.19	0.00	0.00	0.00	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	15.62	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.93	2.41	0.14	0.71	0.43	0.71	0.43	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	45.61	6.80	0.00	0.40	0.40	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	0.52	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	44.60	7.58	0.37	0.62	0.62	0.00	0.99	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	22.81	4.13	0.22	0.65	0.65	0.22	0.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	47.75	6.35	0.37	0.61	0.49	0.00	1.22	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	17.06	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	22.35	1.40	0.00	0.00	0.00	0.70	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	26.53	2.36	0.31	0.00	0.00	0.16	0.47	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	16.50	0.00	0.00	0.00	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	7.13	0.00	0.00	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	12.22	2.93	0.24	0.24	0.00	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.03	2.46	2.05	0.41	0.00	1.64	0.00	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	25.18	7.88	0.11	0.33	0.11	0.33	0.88	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.68	10.08	0.98	1.19	0.76	0.98	0.98	0.65	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.32	8.61	0.36	0.24	0.73	0.24	0.49	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	59.91	14.88	0.14	0.14	0.14	0.00	0.68	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	38.60	15.50	0.42	0.42	0.32	0.63	1.05	0.63	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.19	8.43	1.05	0.53	0.00	0.26	0.26	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.89	5.98	0.66	0.33	0.66	0.33	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	17.24	8.17	0.00	0.00	0.45	0.00	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	12.13	0.76	0.76	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.73	2.37	0.16	0.16	0.32	0.32	0.00	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	19.10	6.97	0.00	0.30	0.61	0.30	0.91	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	22.84	5.20	0.13	0.25	0.63	0.38	0.63	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	18.49	5.15	0.00	0.00	0.15	0.61	0.15	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.13	6.97	0.67	0.67	0.94	0.80	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.02	6.04	0.00	0.43	0.00	1.29	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	4.39	0.00	0.00	0.00	0.00	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	13.38	4.61	0.92	0.92	0.46	0.69	0.00	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	8.82	3.39	0.85	0.34	0.51	0.34	0.51	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	5.63	1.17	0.00	0.23	0.00	0.70	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.79	2.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.52	2.06	0.12	0.36	0.00	0.24	0.24	0.00	0.24
Fibroblast - Dermal, donor4	11450-119A1	15.94	4.30	0.34	0.11	0.11	0.00	0.57	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	22.50	6.11	0.00	0.35	0.17	0.00	0.87	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	24.53	6.82	0.16	0.16	0.16	0.32	0.81	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	20.20	5.83	0.00	0.21	0.62	0.21	0.62	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	29.87	11.27	0.52	1.31	0.00	1.05	0.26	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	8.83	3.03	0.13	0.40	0.13	0.13	0.79	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	28.91	5.90	0.19	0.68	0.68	0.48	0.68	0.58	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	5.19	1.04	0.00	0.00	0.00	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.08	10.22	2.11	1.41	0.53	0.53	0.88	0.18	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.24	10.60	0.16	0.31	0.78	0.16	0.31	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.56	7.03	0.00	0.27	0.14	0.14	0.54	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	39.17	20.82	1.41	0.71	1.41	0.35	1.06	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.34	9.65	0.44	0.44	0.15	0.00	1.02	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.82	9.00	0.00	0.41	0.14	0.14	0.14	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.96	8.12	0.33	0.33	0.22	0.22	0.77	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	28.32	13.65	0.88	1.17	1.32	0.59	1.03	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	4.48	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	5.49	1.69	0.21	0.00	0.84	0.21	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	6.66	0.00	1.67	0.00	0.83	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	4.20	0.00	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	2.24	0.00	0.00	0.00	0.00	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	26.79	8.53	0.41	0.41	0.00	0.00	0.00	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	3.99	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	0.00	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.59	5.24	0.19	0.19	0.19	0.39	0.39	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.48	6.07	0.76	0.15	0.15	0.15	1.21	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.01	5.51	0.00	0.61	0.00	0.00	0.92	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	23.66	7.25	0.38	0.00	0.00	0.00	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.89	12.96	0.27	0.54	1.08	0.00	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.30	8.81	0.46	0.46	0.46	0.12	0.35	0.46	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	22.88	5.75	0.33	0.33	0.11	0.44	0.77	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.46	4.06	0.00	0.61	0.20	1.42	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	7.12	0.79	0.40	0.00	0.40	0.00	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.62	7.74	0.00	0.40	0.00	0.60	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.38	7.82	1.60	0.36	0.53	0.53	0.36	0.89	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	45.13	13.60	0.59	0.20	0.20	0.59	0.59	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	22.56	6.02	0.00	0.30	0.00	0.00	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.49	10.90	0.76	0.54	0.32	0.43	0.32	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.28	11.64	0.25	0.25	1.01	0.00	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	23.96	6.89	0.33	0.33	0.49	0.16	0.49	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	24.26	6.22	0.00	0.40	0.00	0.40	0.60	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	15.37	4.92	0.10	0.60	0.10	0.20	0.20	0.10	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.50	13.90	0.60	0.30	0.60	0.30	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	42.00	14.00	0.58	0.33	0.50	0.58	0.91	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.22	6.33	0.68	0.68	0.34	0.17	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.44	4.60	0.33	0.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.62	5.65	0.53	0.43	0.32	0.11	0.32	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	22.60	4.22	0.00	0.51	0.34	0.34	0.51	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.49	4.70	0.63	0.47	0.78	0.31	0.00	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	3.49	2.61	1.74	0.00	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.34	6.41	0.35	0.00	0.00	0.00	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	64.54	9.37	0.00	0.00	0.00	0.00	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.03	4.60	0.00	0.26	0.00	0.00	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	3.06	0.00	0.00	1.53	0.00	0.77	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	7.66	1.91	1.28	1.28	1.91	1.28	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	7.13	4.28	1.43	3.14	3.42	2.57	0.86	0.57	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	0.83	1.10	3.58	1.93	3.31	1.93	0.83	0.83	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1.37	2.74	2.51	3.42	1.37	2.97	0.23	0.68	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	6.74	1.98	3.76	2.58	1.59	2.97	1.39	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	0.79	1.06	1.85	1.85	3.70	1.32	0.53	0.79	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	1.96	2.94	3.26	2.94	3.91	2.61	0.33	2.28	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.54	4.86	1.77	1.33	2.21	2.21	1.33	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.67	1.98	1.70	1.13	0.57	1.98	0.28	0.57	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.16	3.69	1.85	0.86	1.11	1.35	0.62	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.37	3.22	1.34	1.34	1.07	1.88	0.81	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	11.52	2.48	1.73	1.12	0.62	0.62	0.62	0.50	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	9.55	1.66	0.83	0.28	1.11	0.55	1.25	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.21	4.47	0.41	0.20	0.20	0.61	0.20	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	6.39	2.28	2.05	1.60	0.91	0.68	0.00	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.22	2.74	1.12	0.50	0.62	0.62	0.37	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.87	3.93	1.09	0.66	0.87	0.87	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	5.61	1.48	2.36	0.89	1.18	0.30	0.30	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	8.27	2.23	2.38	0.79	1.27	1.11	0.16	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	8.71	2.46	0.67	1.12	0.22	0.45	0.45	0.67	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	3.02	2.22	2.42	1.61	0.60	1.41	0.20	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	4.58	2.37	2.21	1.87	0.51	0.85	0.51	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	13.48	4.88	1.42	1.33	0.89	1.06	0.35	0.35	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	3.23	1.04	1.77	0.83	1.04	1.25	0.00	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2.05	0.68	1.54	1.37	0.68	1.02	0.17	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	3.32	1.22	1.66	1.33	1.44	1.88	0.33	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.65	3.83	2.33	1.08	1.00	0.75	0.33	0.25	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	7.76	2.45	1.43	0.00	0.41	0.41	0.20	0.20	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	2.48	1.24	1.03	0.83	0.62	1.03	0.21	0.00	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	2.88	1.50	2.08	1.61	1.27	1.84	0.12	0.23	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.50	2.17	1.00	1.33	0.33	0.50	0.17	0.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1.54	2.20	1.54	1.32	0.22	0.44	0.22	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	3.32	2.21	1.84	1.35	0.61	1.11	0.37	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	7.29	3.89	2.11	1.46	0.49	1.13	0.32	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	4.49	0.64	1.92	1.60	1.60	1.60	0.00	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1.99	0.66	1.90	0.85	0.85	0.85	0.09	0.57	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	3.64	2.37	0.79	0.79	0.95	1.58	0.00	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	2.74	2.13	1.82	0.30	1.22	1.22	0.00	0.30	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	3.97	1.99	1.36	0.73	0.63	1.05	0.21	0.63	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	5.05	2.42	1.54	1.32	1.76	2.20	0.22	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.17	0.84	1.96	0.28	1.40	1.68	0.28	1.12	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	4.72	2.50	1.20	0.83	0.83	0.65	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.56	3.74	0.80	0.80	0.00	1.07	0.00	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.96	4.74	0.92	0.61	0.77	0.61	0.15	0.31	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.51	3.50	0.65	0.39	0.39	0.65	0.52	0.52	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	3.80	3.25	2.44	1.63	1.63	2.44	0.00	0.27	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	2.77	2.21	0.92	0.55	1.29	1.11	0.00	0.55	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.92	2.19	0.66	0.66	1.32	0.66	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3.97	2.98	1.98	0.99	0.99	0.99	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.76	4.49	1.58	0.66	0.92	1.19	0.40	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.54	4.24	1.01	0.61	0.61	1.21	0.61	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	4.57	2.80	1.02	1.27	1.27	1.27	0.25	0.76	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	5.77	1.79	1.19	1.39	1.79	2.19	0.40	0.60	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.24	2.93	1.39	1.69	0.62	1.85	1.08	1.08	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.30	2.86	2.25	1.02	0.61	1.23	1.23	0.61	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.76	4.38	0.63	0.31	0.63	0.94	1.25	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	2.26	0.85	2.26	1.13	1.41	0.28	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	3.23	1.84	2.31	1.84	2.31	1.38	0.00	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	2.47	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.74	4.25	0.00	1.55	1.55	1.16	0.00	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	8.02	1.60	3.21	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	5.22	1.74	1.74	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.56	2.28	0.98	0.33	0.98	1.63	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.53	2.88	1.24	3.71	0.82	0.82	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1.96	2.24	2.24	1.68	0.84	1.12	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	3.27	3.27	0.65	0.98	0.33	0.98	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	0.84	0.84	0.84	1.68	1.68	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3.18	2.86	0.64	0.95	0.32	0.95	0.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	2.38	2.04	0.00	1.02	0.34	0.68	0.00	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2.29	1.72	1.72	0.57	0.00	0.57	0.00	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.37	0.89	1.18	0.59	0.30	0.89	0.00	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	1.69	0.00	1.69	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	2.90	3.31	1.66	1.66	0.83	0.41	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	2.99	1.61	0.23	1.15	0.46	0.00	0.23	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	0.00	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	2.31	1.92	0.38	1.15	0.38	0.38	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	2.93	2.61	0.65	0.98	1.30	0.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	5.35	1.34	1.34	0.67	1.34	3.34	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	0.39	1.93	1.16	1.54	1.16	0.00	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.59	6.16	1.37	2.05	0.34	1.71	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	0.00	0.00	0.00	0.00	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1.89	1.42	1.89	0.94	0.00	0.94	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4.22	2.41	0.60	1.81	0.60	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	2.03	1.02	3.56	1.53	1.53	2.54	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1.60	0.80	1.60	1.60	1.60	1.20	0.40	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2.47	1.48	0.99	0.99	1.48	2.47	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2.36	1.18	0.00	2.36	2.36	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.92	0.58	1.17	2.92	0.58	1.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.76	0.88	0.88	0.44	2.19	1.76	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1.70	1.70	1.70	0.00	0.85	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	0.00	0.60	0.00	1.79	0.00	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1.94	0.97	0.49	0.97	0.49	0.49	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	11.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.62	8.73	0.00	0.42	0.00	0.00	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	5.62	1.12	0.00	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.51	3.81	0.32	0.32	0.00	0.00	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	3.76	0.42	0.00	0.00	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.38	8.47	0.58	0.35	0.81	0.35	0.23	0.35	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.26	10.97	0.51	0.17	0.68	0.00	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.11	8.65	0.46	0.91	0.91	0.23	0.00	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.80	8.85	0.66	1.20	0.66	0.11	0.33	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.19	6.45	0.43	0.21	0.43	0.43	0.21	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.36	7.32	0.43	0.86	0.65	0.65	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.31	7.97	0.25	1.00	0.37	0.37	0.25	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.27	8.75	0.51	1.03	0.17	0.34	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.53	8.33	0.32	0.64	0.64	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	7.28	0.00	0.56	1.12	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	2.16	0.00	0.43	0.00	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.76	3.17	0.00	0.71	0.00	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	16.26	4.72	0.17	0.35	0.35	0.52	0.35	0.00	0.35
Hepatocyte, donor1	11523-119I2	15.74	10.90	0.00	0.00	1.21	0.00	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	20.47	10.77	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	29.45	14.72	1.23	2.45	1.23	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	3.92	4.57	3.26	1.96	7.18	0.00	2.61	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	2.62	1.92	0.87	0.52	0.00	0.35	0.17	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.03	6.45	0.00	0.41	0.14	0.14	0.55	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	0.00	0.00	0.00	0.00	0.00	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	1.32	0.00	0.00	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	29.60	5.04	0.00	0.00	0.63	0.00	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	3.09	0.00	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	48.45	3.23	0.00	0.00	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	3.22	0.00	0.00	0.00	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	46.18	2.94	0.42	0.00	0.00	0.00	2.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	36.97	3.21	0.00	0.00	0.00	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	36.01	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	37.29	1.89	0.00	0.00	0.00	0.00	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	5.44	0.00	0.00	0.00	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	1.08	0.00	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	1.28	0.64	0.00	0.00	0.00	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	5.47	1.82	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	3.57	0.71	0.00	0.00	0.00	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.32	2.16	0.00	0.00	0.62	0.31	1.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.90	0.70	0.70	0.00	0.00	0.00	2.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	3.24	0.00	0.00	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.05	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	2.25	0.00	0.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	0.00	0.00	0.00	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	1.39	0.00	0.00	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	36.82	0.92	0.00	0.92	0.00	0.00	1.84	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	5.29	0.00	0.00	0.00	0.00	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	28.31	7.59	0.08	0.16	0.16	0.41	0.16	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	6.44	0.00	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.17	4.07	0.19	0.19	0.28	0.19	0.19	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	12.83	3.97	1.25	0.34	0.57	0.23	0.23	0.23	0.34
Keratocytes, donor1	11527-119I6	12.38	5.16	0.00	0.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	32.81	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	30.63	6.52	0.59	0.40	0.79	0.59	0.99	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	0.00	0.00	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	8.63	0.00	0.00	0.00	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	4.04	2.42	0.92	0.81	0.46	0.69	0.12	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	15.54	5.85	0.50	0.50	0.30	0.40	0.50	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	22.65	4.98	0.36	0.36	0.24	0.12	0.59	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.21	4.19	0.00	0.28	0.28	0.00	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.66	6.77	0.31	0.79	0.47	0.00	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.21	2.69	0.00	0.00	0.00	0.00	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.72	4.41	0.32	0.63	0.00	0.63	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.69	2.16	0.22	0.00	0.22	0.00	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.44	3.28	0.00	0.41	0.41	0.00	0.41	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.12	2.02	0.25	0.25	0.25	0.51	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.48	2.96	0.00	0.42	0.00	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	24.13	5.93	0.79	0.40	0.00	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.96	2.13	0.19	0.58	0.00	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.70	2.59	0.19	0.37	0.19	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	3.14	0.35	0.70	0.00	0.00	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.36	3.10	0.24	0.24	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.26	3.02	0.14	0.41	0.00	0.14	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.17	3.70	0.31	0.31	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	1.87	0.00	0.00	0.31	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.19	3.29	0.00	0.37	0.37	0.00	0.55	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.39	4.28	0.66	0.66	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	2.34	0.59	0.29	0.00	0.29	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.20	1.24	0.75	0.00	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	5.33	0.48	1.45	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.58	5.12	0.27	0.27	0.00	0.27	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.05	2.88	0.30	0.30	0.00	0.15	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.85	1.56	0.52	0.52	0.00	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.66	5.23	0.21	0.42	0.42	0.00	0.63	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.64	3.61	0.30	0.45	0.00	0.15	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.70	3.44	0.00	0.00	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	17.12	2.07	0.00	0.38	0.00	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.60	2.54	0.32	0.32	0.21	0.11	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.87	1.94	0.00	0.48	0.00	0.00	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.19	1.32	0.66	0.33	0.00	0.33	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.04	2.85	0.37	0.00	0.37	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	6.66	0.74	0.74	0.37	0.37	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.00	1.98	0.25	0.49	0.00	0.49	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	12.65	1.10	0.14	0.00	0.14	0.14	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	22.51	4.82	0.32	0.00	0.00	0.32	0.96	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	4.56	0.00	0.30	0.00	0.61	1.52	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.67	4.76	0.42	0.28	0.56	0.42	0.84	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.40	7.11	0.36	0.36	0.00	0.36	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	1.45	0.00	0.48	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.71	1.09	0.31	0.62	0.00	0.16	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.93	3.58	0.00	0.36	0.00	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.03	2.29	0.00	0.33	0.33	0.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.89	2.35	0.00	0.00	0.00	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.12	4.46	0.00	0.25	0.00	0.00	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.60	2.05	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.74	2.69	0.00	0.30	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	2.27	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.90	1.53	0.77	0.00	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.74	2.23	0.00	0.00	0.00	0.00	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	3.39	3.81	1.27	0.00	0.42	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	2.81	0.00	0.00	0.00	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.93	0.00	0.93	0.93	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1.55	1.55	1.03	0.00	0.00	0.52	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	1.19	0.00	1.19	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.26	1.36	0.68	0.68	0.23	0.68	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2.04	3.20	1.74	0.00	0.29	0.29	0.29	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.05	1.35	0.45	0.90	0.45	0.45	0.45	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3.25	2.03	0.95	0.27	0.27	0.27	0.00	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.59	2.57	1.03	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	2.47	2.82	1.06	0.71	0.35	0.35	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	0.00	0.00	0.00	0.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.09	2.04	1.53	1.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	3.47	2.13	1.87	0.00	0.53	0.00	0.00	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	2.65	2.83	1.13	0.38	0.57	1.32	0.38	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	3.07	1.23	0.61	1.23	0.61	1.23	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1.63	4.89	2.45	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4.58	2.50	0.42	0.62	0.83	1.04	0.21	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1.12	2.24	0.84	0.56	1.12	0.56	0.00	0.84	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	4.12	2.06	2.06	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	2.90	2.90	1.16	0.58	0.00	1.45	0.29	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	3.89	2.39	0.30	0.00	0.60	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3.32	1.66	1.11	0.55	0.00	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2.12	1.77	1.41	0.71	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2.21	2.95	1.84	0.74	0.37	0.37	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	2.30	1.15	0.00	0.00	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2.30	4.61	1.15	1.15	0.38	0.00	0.00	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	3.96	1.13	0.00	0.57	0.57	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	3.28	2.46	0.82	0.00	1.64	0.82	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	4.07	1.36	1.81	0.00	0.00	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.72	2.15	1.44	0.72	0.00	1.44	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3.73	6.72	1.49	0.00	2.24	0.75	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	3.34	2.60	1.11	0.37	0.74	0.74	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.88	0.86	1.29	0.43	0.43	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.86	0.00	0.86	0.86	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	3.66	1.33	0.67	0.33	1.00	0.33	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.02	1.81	1.21	0.60	1.21	0.00	0.00	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	2.13	2.13	0.71	0.00	2.13	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.44	2.06	1.03	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1.07	2.15	1.07	0.00	0.54	0.54	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.02	2.69	0.67	0.00	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2.22	2.22	1.85	0.37	0.74	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	1.16	1.16	1.16	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2.12	0.00	0.00	0.00	0.00	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.00	4.40	0.40	0.00	0.40	0.40	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.18	2.18	2.18	0.73	0.73	0.00	0.00	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1.53	0.77	0.77	0.00	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	4.93	1.97	1.48	0.49	0.00	2.47	0.00	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1.88	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1.51	1.51	0.50	1.01	1.51	1.01	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	2.25	0.90	1.80	0.45	0.00	0.45	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	2.23	1.78	0.45	0.45	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.56	4.69	1.17	0.39	1.56	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	4.62	1.98	1.32	0.00	0.00	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	2.59	2.59	0.00	0.52	0.00	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2.63	2.19	0.88	1.31	0.44	0.44	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2.24	1.12	2.80	0.00	1.12	0.56	0.00	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1.77	2.21	0.88	0.88	0.00	0.88	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.47	3.09	0.77	0.39	0.39	0.77	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	2.53	4.05	2.03	1.01	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.44	1.44	0.00	0.00	0.00	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3.18	3.18	0.40	0.40	0.80	0.40	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	3.65	3.65	1.22	0.61	0.00	0.00	0.00	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	2.08	0.00	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1.90	1.90	0.38	0.00	1.14	0.76	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	3.10	2.58	0.52	0.52	0.00	1.03	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.63	2.42	0.60	0.00	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	4.75	3.17	0.95	0.32	0.63	0.32	0.00	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3.20	4.26	0.53	0.00	0.00	0.53	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	3.45	2.87	1.15	0.57	0.57	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1.54	2.06	2.06	1.03	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	2.12	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2.27	3.40	1.13	0.57	0.00	1.13	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	4.58	3.33	0.00	0.83	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	3.92	0.00	1.57	2.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.34	2.51	0.00	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.86	1.39	0.93	0.46	0.00	0.46	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.02	4.01	0.00	0.00	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.74	4.28	0.53	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.04	3.64	0.81	0.00	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	2.75	2.75	0.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	1.78	1.78	0.89	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1.71	1.14	0.57	0.00	0.00	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	0.77	0.00	0.00	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.55	2.19	0.00	0.00	1.64	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	3.56	1.34	0.45	0.89	0.45	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.86	1.30	1.56	0.52	0.26	0.52	0.26	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2.65	3.32	1.99	0.66	1.99	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	6.24	2.08	0.00	0.00	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	10.94	2.28	0.68	0.46	0.46	0.00	0.00	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	11.56	2.20	0.18	0.55	0.55	0.00	0.00	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	7.34	3.15	0.66	1.31	1.05	0.39	0.13	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	78.06	5.84	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	28.20	3.80	0.16	0.00	0.00	0.00	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	34.47	6.39	0.14	0.00	0.00	0.00	0.28	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	35.17	8.77	0.90	0.30	0.50	0.50	0.30	0.60	0.30
Mammary Epithelial Cell, donor2	11350-117G9	43.14	13.32	1.16	0.00	0.87	0.87	0.29	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	31.43	8.98	0.25	0.00	0.25	0.00	0.25	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	22.37	7.46	2.03	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	12.76	5.19	1.30	1.62	0.65	0.54	0.43	0.22	0.54
Mast cell, donor2	11565-120D8	3.57	1.19	0.30	0.30	0.59	0.30	0.00	0.59	0.30
Mast cell, donor3	11566-120D9	1.58	0.68	0.68	0.68	0.23	0.45	0.00	0.23	0.45
Mast cell, donor4	11567-120E1	1.77	1.95	0.18	0.71	0.35	0.89	0.18	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	17.74	10.98	1.55	2.55	0.55	0.55	0.22	0.11	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	43.19	23.93	2.33	1.75	1.75	2.92	1.17	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	15.49	10.21	1.61	2.64	1.15	0.57	0.34	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	19.92	13.39	0.84	2.85	1.00	1.51	0.50	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	27.46	7.76	0.30	1.09	0.60	0.30	0.10	0.50	0.00
Melanocyte - dark, donor2	11582-120F7	14.88	5.19	0.00	0.00	0.00	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	2.17	2.97	1.52	1.45	0.72	0.43	0.00	0.87	0.22
Melanocyte - light, donor1	11274-116H5	2.59	1.65	0.47	0.24	0.71	0.00	0.00	0.71	0.00
Melanocyte - light, donor2	11351-117H1	0.68	0.00	1.36	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.00	0.00	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.95	4.06	1.15	0.94	0.83	0.10	0.10	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	10.76	2.96	0.81	1.08	0.81	1.08	0.27	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	6.43	3.21	0.80	0.80	1.07	0.00	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	17.86	3.72	0.62	0.50	0.37	0.50	0.99	0.50	0.00
Meningeal Cells, donor2	11573-120E7	8.36	4.40	0.44	0.44	0.88	0.00	0.88	0.88	0.00
Meningeal Cells, donor3	11654-122E7	30.48	7.01	0.16	0.16	0.24	0.33	3.91	0.16	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.12	4.28	0.00	0.00	0.29	0.57	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.12	5.43	0.20	0.30	0.30	0.10	0.10	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	2.62	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	8.61	0.00	0.72	0.00	0.00	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.80	3.39	1.27	0.64	0.21	0.42	0.21	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	6.03	0.50	0.50	0.50	0.00	0.00	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.75	4.40	0.44	0.44	0.22	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	3.65	0.00	0.00	0.73	0.00	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.30	3.68	0.61	0.61	0.00	0.61	0.41	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.31	2.63	0.28	0.55	0.00	0.55	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.64	3.35	0.37	0.00	0.00	1.12	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	76.84	29.74	0.92	1.32	0.66	1.05	1.45	1.05	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	1.78	0.30	0.59	0.30	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	10.25	1.28	0.00	1.28	1.92	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.67	12.05	0.35	0.00	0.00	0.00	1.42	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	60.67	18.14	1.25	0.63	0.63	1.25	0.63	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.06	5.08	0.00	0.73	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	33.41	8.22	0.00	0.53	0.27	0.00	1.33	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	31.03	8.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	29.27	8.24	0.36	0.22	0.43	0.14	0.22	0.07	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	1.35	0.00	0.00	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.07	4.43	1.72	0.49	0.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.66	5.30	0.29	1.77	0.59	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	10.37	0.00	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	1.86	0.62	0.93	0.00	0.00	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.43	3.73	0.00	0.21	0.62	0.21	0.00	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.51	3.50	0.25	0.00	0.50	0.25	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.45	2.79	0.47	0.93	0.47	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.71	2.24	1.42	0.61	0.61	0.20	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.69	3.56	0.40	0.40	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	2.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	3.80	0.38	0.76	0.76	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.06	2.33	0.21	0.21	0.00	0.00	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.35	2.98	0.30	0.00	0.60	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.29	4.27	1.25	0.50	0.25	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.32	3.33	0.95	0.48	0.71	0.00	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.90	1.66	0.55	0.00	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.40	2.30	0.00	0.00	0.00	0.00	0.23	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.04	4.42	0.84	0.21	0.21	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.14	1.02	0.41	0.00	0.61	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	1.07	0.21	0.43	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.00	3.56	0.44	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.34	2.63	0.44	0.00	0.22	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	1.66	0.00	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	21.20	2.72	0.27	0.00	0.27	0.54	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.41	4.71	0.29	0.29	0.59	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.95	1.44	0.96	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.82	6.00	0.00	0.40	0.00	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.03	5.51	0.00	0.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	53.89	0.00	0.00	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.46	0.88	0.44	0.00	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	1.28	0.00	0.64	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.30	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.65	2.39	0.00	0.34	0.34	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.07	2.63	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.62	0.71	0.36	0.00	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.06	1.40	0.00	0.00	0.00	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	2.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.08	3.02	0.30	0.00	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	2.92	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.04	1.14	0.00	0.57	0.57	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.40	1.93	0.14	0.00	0.14	0.14	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.44	2.07	0.26	0.26	0.00	0.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.44	2.14	0.00	0.00	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.81	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	3.89	0.00	0.00	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.75	1.41	0.00	0.00	0.14	0.14	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	3.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	26.31	3.10	0.00	0.00	0.44	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	1.90	0.00	0.38	0.00	0.38	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.92	2.84	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.46	5.90	0.25	0.00	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	1.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.64	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	34.60	6.05	0.00	0.29	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	3.30	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.27	4.17	0.30	0.60	0.30	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	3.94	0.66	0.00	0.33	0.99	0.00	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	3.16	3.16	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	9.29	2.97	0.59	0.20	0.40	0.59	0.40	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	1.86	0.00	0.93	1.86	2.79	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.50	3.38	1.50	0.00	0.00	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.66	2.93	1.07	0.00	0.27	0.53	0.00	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.20	2.26	0.68	0.11	0.23	0.23	0.11	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	0.74	0.74	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.50	1.83	0.00	0.00	0.37	0.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	3.21	0.53	0.00	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	2.11	0.42	0.84	0.00	0.00	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.00	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	9.50	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.68	4.74	0.00	0.86	0.00	0.65	1.08	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	1.57	2.09	1.05	0.00	2.61	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	7.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.03	1.67	0.00	0.42	0.00	0.00	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.17	4.56	0.38	0.38	0.00	0.00	0.19	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	4.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	1.84	0.00	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	5.86	0.84	0.84	0.00	0.84	2.09	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.67	5.11	0.23	0.00	0.46	0.00	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	4.86	1.08	0.27	0.27	0.27	0.54	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.88	4.41	0.00	0.00	0.84	0.00	0.63	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	5.46	0.99	0.50	0.00	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	5.14	0.27	0.00	0.54	0.27	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.39	3.63	0.45	0.23	0.00	0.00	0.45	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.41	6.04	0.49	0.33	0.33	0.16	1.31	0.49	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.66	4.56	0.00	0.73	0.00	0.00	0.73	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	6.90	0.53	0.00	0.53	0.00	1.06	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	8.40	0.00	1.20	1.20	0.00	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3.94	2.95	0.00	0.33	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.25	4.39	0.16	0.16	0.49	0.00	0.33	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.46	3.88	1.06	0.18	0.18	0.18	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	10.55	0.70	0.70	0.00	0.00	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	0.92	0.46	0.00	0.00	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	9.32	0.96	0.64	0.32	0.00	1.61	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.07	2.76	0.69	0.69	0.69	0.69	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	2.53	0.00	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.92	4.23	0.22	0.89	0.22	0.00	0.22	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	6.35	0.85	0.42	0.42	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.31	3.80	0.71	0.24	0.71	0.00	0.47	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	31.34	14.59	1.29	0.86	1.29	0.86	0.86	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.33	7.33	1.33	0.33	1.33	1.33	0.33	1.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	5.86	1.35	0.00	0.45	0.00	0.45	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	21.82	1.19	0.40	0.40	1.59	0.00	1.98	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	6.50	0.00	0.00	0.93	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.38	21.57	0.38	0.38	0.76	0.38	1.89	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.70	12.71	1.96	1.96	0.00	1.63	0.65	0.98	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.38	4.79	1.31	0.87	0.44	0.87	0.87	0.44	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	9.95	0.00	0.45	0.00	1.36	0.45	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	20.28	1.76	0.00	1.76	0.00	0.88	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	7.31	1.99	0.66	0.00	0.00	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.72	15.87	2.48	0.99	0.50	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	25.65	14.16	1.53	0.38	1.15	0.77	1.53	1.53	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.91	11.49	1.51	0.30	0.60	1.51	0.60	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.87	13.26	0.44	0.22	0.22	0.22	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	37.95	1.36	0.68	1.36	0.00	2.03	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	23.17	3.66	0.61	1.22	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	33.99	21.40	2.52	0.00	1.57	1.26	0.31	0.63	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.08	7.57	0.61	0.30	0.61	0.30	0.30	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	35.60	20.57	2.37	0.79	1.58	0.79	0.79	0.79	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	12.47	1.13	0.00	0.00	0.00	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	21.99	5.71	0.12	0.00	0.12	0.00	0.50	0.00	0.12
Myoblast, donor2	11322-117D8	16.88	2.88	0.19	0.19	0.19	0.00	0.19	0.00	0.19
Myoblast, donor3	11398-118D3	19.84	6.05	0.00	0.17	0.00	0.17	0.67	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.13	6.86	3.21	1.75	0.88	3.65	0.73	1.61	1.46
Natural Killer Cells, donor1	11230-116C6	3.38	4.31	3.38	1.85	1.85	1.85	0.31	0.62	0.92
Natural Killer Cells, donor2	11311-117C6	3.32	6.94	3.92	1.51	0.30	2.71	0.00	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	3.31	4.60	2.94	1.47	0.55	1.66	0.00	0.92	0.74
Neural stem cells, donor1	11275-116H6	27.58	12.70	1.45	1.09	1.09	2.18	1.45	0.36	0.36
Neural stem cells, donor2	11352-117H2	11.55	9.63	0.00	1.93	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	13.65	4.55	1.14	0.00	0.00	3.41	0.00	0.00	0.00
Neurons, donor2	11574-120E8	6.38	0.66	0.88	0.66	0.66	0.88	0.00	1.54	0.88
Neurons, donor3	11655-122E8	7.40	9.87	0.82	0.00	2.47	2.47	0.00	2.47	0.82
Neutrophils, donor1	11233-116C9	9.28	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	34.21	5.50	0.00	0.61	0.61	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	25.88	8.91	1.31	1.07	0.59	0.71	0.47	0.83	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	13.35	7.49	0.33	0.65	0.33	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	12.63	4.81	0.40	0.60	0.00	0.80	0.80	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	18.31	5.64	0.14	0.69	0.28	0.28	0.28	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	27.07	12.59	0.14	0.72	0.87	0.29	0.29	0.14	0.43
Olfactory epithelial cells, donor3	11935-125I9	19.41	11.01	0.68	1.14	0.57	0.34	0.23	0.34	0.23
Olfactory epithelial cells, donor4	11936-126A1	27.08	10.81	0.78	1.17	0.58	0.97	0.58	0.10	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	13.24	4.21	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.89	0.85	0.85	0.00	0.21	0.85	0.00	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	6.86	3.43	1.14	0.00	0.00	1.14	0.00	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	4.34	2.48	0.00	1.24	0.00	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	6.45	2.35	0.20	0.59	0.39	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	19.66	4.92	0.70	0.70	1.40	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	13.69	2.67	0.18	0.18	0.00	0.36	0.71	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	17.77	3.45	0.17	0.25	0.34	0.25	0.25	0.08	0.08
Pericytes, donor1	11491-119E6	6.79	1.67	0.45	0.11	0.11	0.78	0.33	0.11	0.11
Pericytes, donor2	11571-120E5	3.62	2.04	1.13	0.45	0.68	0.68	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	22.18	5.70	0.20	0.20	0.00	0.20	0.61	0.20	0.20
Perineurial Cells, donor1	11499-119F5	22.83	8.48	0.68	0.45	0.11	0.34	2.71	0.34	0.23
Perineurial Cells, donor2	11579-120F4	19.05	5.89	0.28	0.28	0.18	0.00	0.83	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2.23	0.32	1.91	0.96	0.64	2.55	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	2.69	1.47	0.24	0.49	0.00	1.96	0.24	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	2.59	4.14	1.42	1.55	0.65	2.72	0.13	0.00	0.91
Placental Epithelial Cells, donor1	11278-116H9	22.24	5.50	0.24	0.00	0.00	0.00	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.71	2.16	0.59	0.20	0.39	0.79	0.00	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.34	4.75	0.32	0.00	0.32	0.32	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	24.57	8.25	0.75	0.94	0.19	0.38	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.97	6.92	1.17	0.78	0.39	0.26	0.00	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	18.91	5.85	0.68	0.23	0.68	0.90	0.45	0.23	1.13
Preadipocyte - omental, donor1	11468-119C1	33.89	9.48	0.85	0.43	0.32	0.53	0.32	0.85	0.53
Preadipocyte - omental, donor2	11329-117E6	25.32	6.98	0.44	0.44	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	17.19	5.44	0.29	0.14	0.00	0.43	0.29	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	12.80	0.98	0.00	0.00	0.00	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.48	9.21	0.00	0.00	0.00	0.00	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	48.70	14.52	0.00	0.35	0.35	0.00	1.24	0.00	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	49.55	14.81	0.17	0.34	0.00	1.02	1.19	0.17	0.34
Preadipocyte - visceral, donor1	11280-116I2	55.89	12.39	0.00	0.56	0.19	0.00	0.93	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	50.62	14.73	0.46	0.00	0.46	0.00	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	30.82	6.58	0.00	0.21	0.10	0.00	0.21	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	6.03	2.72	0.91	0.45	0.45	0.60	0.15	0.45	0.30
Prostate Epithelial Cells, donor2	11331-117E8	54.84	14.22	0.00	0.14	0.14	0.00	0.54	0.54	0.00
Prostate Epithelial Cells, donor3	11404-118D9	16.47	3.49	0.12	0.12	0.06	0.12	0.06	0.06	0.18
Prostate Stromal Cells, donor1	11254-116F3	98.30	28.48	0.34	0.80	0.57	0.11	2.39	0.46	0.23
Prostate Stromal Cells, donor2	11332-117E9	58.63	12.19	0.36	0.36	0.18	0.18	0.36	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	71.01	22.94	0.63	0.52	0.73	0.63	2.92	0.21	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.96	4.38	0.00	0.00	0.00	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.77	5.89	0.00	0.28	0.07	0.14	0.55	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	13.70	3.04	0.51	0.51	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	2.85	0.71	0.00	0.00	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	20.33	5.93	0.42	0.42	0.00	0.21	1.06	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	3.40	0.00	0.00	1.36	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.85	5.39	0.54	0.13	0.40	0.00	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.32	4.66	0.22	0.44	0.00	0.67	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.94	3.74	0.66	0.44	0.22	0.22	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	4.39	1.25	1.88	0.63	1.25	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	2.22	0.55	0.83	0.55	0.28	0.00	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	34.89	5.91	0.81	0.54	0.00	0.27	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.60	4.22	0.00	1.27	0.00	0.00	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.92	4.24	0.39	0.39	0.00	0.96	0.77	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.11	4.93	1.56	0.26	1.30	0.52	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	1.14	0.28	0.28	0.00	0.00	0.28	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00	0.00	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.51	1.51	0.50	0.75	1.00	1.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.64	8.55	1.07	2.14	2.41	0.13	0.53	0.80	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	2.68	4.47	1.79	4.47	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.10	8.26	2.20	7.15	3.30	0.55	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.58	6.38	3.48	1.16	2.90	1.74	0.00	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.48	10.79	2.86	4.16	4.29	1.56	0.39	0.39	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.68	16.29	5.46	5.66	4.07	3.28	0.79	1.69	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.87	15.28	4.91	5.24	3.90	2.23	0.56	2.23	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.61	21.21	3.35	6.33	4.09	3.10	0.50	1.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	14.57	13.29	4.31	4.20	5.24	2.80	0.23	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.72	15.25	3.70	5.78	8.32	3.24	0.46	2.31	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.72	11.50	2.74	3.29	2.05	2.60	0.27	1.51	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	11.50	11.50	5.14	3.63	4.39	2.72	0.15	0.91	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.81	13.26	3.58	4.30	3.58	2.87	0.18	0.72	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.19	13.05	4.02	4.59	3.30	2.73	0.43	0.86	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.34	12.23	3.65	4.29	4.72	3.33	0.54	0.86	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.61	15.05	4.20	4.43	5.75	2.88	0.22	1.55	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.66	15.87	2.68	4.21	1.34	2.49	0.00	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.42	11.92	4.19	4.56	4.01	1.77	0.47	1.68	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.80	17.29	4.13	5.64	3.76	2.82	0.19	2.44	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.39	12.08	3.72	3.18	1.86	3.18	0.27	0.27	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.99	13.73	4.28	3.80	3.99	3.21	0.00	0.88	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.10	17.95	5.92	5.54	4.01	2.86	0.00	1.34	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	16.34	15.16	2.46	4.81	3.31	2.78	0.11	1.39	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.86	14.02	3.92	4.77	2.24	5.05	0.00	1.96	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.68	16.06	3.25	3.25	3.42	2.56	0.17	1.37	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	17.69	20.24	4.01	3.28	3.46	4.56	0.18	1.64	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.97	15.94	6.38	3.68	4.29	2.33	0.25	1.23	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.39	20.42	4.84	4.70	4.57	3.90	0.40	1.48	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.13	25.47	5.19	5.90	1.65	2.36	0.47	1.89	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.83	14.09	4.37	2.78	3.17	3.97	0.79	1.98	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	23.15	3.98	5.85	4.21	2.81	0.23	1.87	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.58	25.50	4.77	6.64	3.32	2.70	0.62	0.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.79	19.47	3.76	4.87	4.65	6.86	0.00	1.33	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.99	19.01	4.60	3.13	4.80	2.92	0.42	1.88	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.82	24.63	3.90	5.65	3.10	2.56	0.54	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.52	19.41	3.07	4.43	2.90	2.38	0.17	1.36	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.65	21.79	4.24	5.78	4.43	2.31	0.58	1.74	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.29	23.38	4.13	4.99	2.06	3.44	0.52	1.20	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.04	16.19	4.80	4.94	3.57	3.70	0.96	1.51	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.27	21.34	5.25	5.58	3.45	1.97	0.33	1.97	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.10	11.76	2.73	3.24	2.39	2.05	0.00	1.19	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.39	13.76	5.18	3.55	4.59	2.81	1.04	0.89	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.99	11.99	4.00	2.67	3.20	0.80	0.00	1.60	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	3.18	5.95	5.12	2.07	4.15	3.04	0.00	0.97	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	7.86	6.67	6.90	3.57	3.81	2.62	0.48	1.43	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.05	6.05	5.84	5.44	5.04	2.82	0.81	1.81	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2.07	4.43	3.58	3.58	2.92	4.61	0.09	1.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	4.19	6.64	3.84	4.54	6.64	2.79	0.35	3.49	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	3.93	4.84	7.56	3.32	3.02	3.32	0.00	2.72	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2.69	4.16	3.18	3.43	1.84	3.06	0.24	1.10	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	12.08	10.48	6.70	4.95	4.37	4.80	0.29	2.47	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	4.87	6.69	7.91	4.87	2.43	2.43	0.61	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.01	3.62	3.32	2.11	1.21	3.01	0.00	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2.04	6.33	7.46	3.39	5.20	2.49	0.45	2.26	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	6.59	5.09	7.19	4.19	3.29	3.59	0.00	1.80	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3.07	4.25	4.60	3.07	2.72	3.42	0.35	1.18	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.98	6.40	6.62	4.70	2.56	2.99	0.21	1.49	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	6.01	4.81	5.41	7.81	5.41	2.40	0.00	0.60	2.40
Schwann Cells, donor1	11498-119F4	6.21	1.88	0.75	0.00	0.19	0.38	0.56	0.19	0.00
Schwann Cells, donor2	11578-120F3	27.22	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.36	4.16	0.44	0.22	0.22	0.22	0.88	0.00	0.22
Sebocyte, donor1	11220-116B5	18.62	1.64	0.55	0.00	0.55	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	11.95	3.68	0.46	0.00	0.00	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	8.66	6.60	0.21	0.41	0.41	1.03	0.82	0.21	0.00
Sertoli Cells, donor1	11255-116F4	74.55	34.79	0.00	0.00	0.00	0.00	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	36.72	19.77	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.55	8.53	0.62	0.44	0.88	0.62	0.62	0.18	0.26
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.72	0.72	0.00	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	19.23	3.34	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.36	8.95	0.16	0.00	0.16	0.63	0.31	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	18.88	8.62	0.30	0.45	0.15	0.15	0.45	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	30.93	7.54	0.00	0.31	0.00	0.00	0.62	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.88	7.56	0.38	0.50	0.38	0.13	0.38	0.25	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.99	5.71	0.14	0.29	0.00	1.00	1.14	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.16	9.42	0.60	0.30	0.40	0.40	1.29	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.36	4.97	1.18	0.76	0.51	0.76	0.34	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	3.62	0.00	0.72	0.00	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.16	2.61	0.00	0.28	0.41	0.28	0.28	0.14	0.00
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.34	3.46	0.29	0.14	0.29	0.14	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	26.99	1.64	0.00	0.82	0.00	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.48	6.75	0.39	0.13	0.13	0.78	0.39	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	38.51	4.03	1.11	0.00	0.14	0.14	0.83	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	31.65	4.92	0.56	0.14	0.28	0.42	0.56	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	63.86	11.63	0.63	0.42	0.21	0.21	0.21	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	35.23	7.12	0.67	0.00	0.45	0.15	0.60	0.37	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.05	4.63	0.62	0.00	0.00	0.31	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.46	4.89	0.22	0.22	0.00	0.00	0.44	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.15	4.11	0.00	0.00	0.00	0.00	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.34	3.31	0.44	0.22	0.00	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	2.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.99	3.86	0.00	0.00	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	13.01	1.00	3.00	0.00	5.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.98	2.40	0.00	0.00	0.13	0.00	0.80	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.28	8.20	0.66	0.44	0.44	0.66	0.66	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.69	4.48	0.00	0.26	0.00	0.13	0.64	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.33	5.86	0.00	1.95	0.33	0.00	0.98	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.54	5.91	0.30	0.00	0.30	0.30	0.00	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.12	25.91	0.43	0.14	0.57	0.14	1.57	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.18	1.79	0.00	0.16	0.00	0.33	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	1.83	0.61	0.30	0.61	0.61	0.00	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.28	4.80	0.00	0.25	0.00	0.25	0.76	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.31	2.86	0.00	0.48	0.48	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	39.82	14.16	0.29	0.88	0.44	0.00	0.74	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.47	14.21	0.65	0.65	0.43	0.43	0.43	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.20	11.65	0.42	0.94	0.73	0.63	0.31	0.31	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.17	2.78	0.15	0.00	0.00	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	5.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.10	3.89	0.30	0.30	0.00	0.00	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	3.76	1.02	0.68	0.00	0.34	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	67.22	36.99	1.26	0.71	0.47	1.02	1.41	0.55	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.63	6.14	0.81	0.30	0.50	0.10	0.91	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.37	7.28	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	19.32	2.42	0.00	0.00	0.60	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	23.05	7.95	0.26	0.79	0.26	0.26	0.26	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	49.67	20.24	0.80	1.60	0.67	0.80	1.46	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	80.89	45.33	0.63	1.50	1.38	0.50	2.00	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.86	2.79	0.25	0.51	0.00	0.51	0.00	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.19	6.94	0.15	0.30	0.00	0.00	1.36	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	4.50	0.00	1.50	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	7.75	7.75	1.29	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.93	5.58	0.00	0.47	0.00	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.23	7.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.52	2.82	0.00	0.31	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.01	1.77	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.66	6.83	0.00	0.33	0.00	0.17	0.50	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	0.93	0.00	0.47	0.00	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.92	0.86	0.00	0.14	0.00	0.14	0.58	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	2.55	0.25	0.51	0.00	0.25	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.34	2.82	0.00	0.00	0.19	0.00	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.16	3.07	0.14	0.70	0.14	0.28	0.14	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.41	6.12	0.42	0.34	0.50	0.50	0.08	0.08	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	4.29	0.00	0.00	0.00	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.89	1.47	0.00	0.00	0.00	0.00	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	9.50	0.00	0.44	0.22	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.48	3.51	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.61	4.86	0.39	0.97	0.19	1.36	0.58	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	3.97	0.00	0.26	0.26	0.00	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	22.69	5.95	1.12	0.37	0.00	0.37	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.93	12.22	0.00	0.36	0.00	0.72	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.37	3.97	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.00	5.12	0.00	0.00	0.00	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	23.62	9.90	0.76	1.02	0.25	0.00	1.02	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	30.35	10.38	0.00	0.80	0.80	0.80	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	28.42	11.70	0.00	0.00	0.84	0.42	0.00	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	17.88	10.08	2.29	0.92	0.00	0.92	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.32	5.39	0.34	0.00	0.50	0.34	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	117.17	38.39	0.00	1.17	0.67	0.84	4.53	0.84	0.50
Synoviocyte, donor3	11440-118H9	41.78	13.85	0.67	0.22	1.79	0.22	2.01	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	26.80	7.15	0.00	0.71	0.36	0.36	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	7.93	0.00	0.00	1.98	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.42	3.47	0.93	1.39	0.93	0.69	1.16	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.71	2.58	0.29	0.07	0.07	0.22	0.22	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	2.71	0.00	0.00	0.00	0.39	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	14.89	1.72	0.00	0.00	0.00	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.70	9.60	1.60	1.35	1.60	0.37	0.12	0.86	0.49
Urethra, donor2	10319-105A4	1.80	1.80	1.80	0.00	1.80	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	34.27	3.72	0.00	0.00	0.00	0.00	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	32.45	6.01	0.40	0.00	0.40	0.40	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	25.21	6.88	0.92	0.00	0.23	0.00	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	74.45	20.73	0.67	0.22	0.00	1.11	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	2.67	2.67	0.00	0.00	2.67	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	1.43	4.29	1.43	0.00	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	1.37	2.74	1.37	1.37	0.00	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.05	2.07	2.07	3.10	0.69	1.03	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.88	0.58	2.91	0.58	0.58	0.58	0.00	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	20.82	3.12	2.08	2.08	2.08	2.08	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	2.74	1.83	2.74	0.91	2.74	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	4.93	6.04	0.99	1.73	1.97	0.62	0.12	1.11	0.12
Wilms' tumor cell line:HFWT	10597-108E3	14.08	6.16	5.28	0.88	0.00	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	23.74	3.35	2.23	0.84	0.84	1.12	0.28	0.84	0.28
achilles tendon, donor2	10292-104G4	49.60	6.20	0.00	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2.55	2.80	1.53	3.31	2.04	0.25	0.00	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.70	1.16	3.25	2.79	2.09	2.32	0.23	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.47	4.15	10.09	2.97	3.56	3.80	0.12	1.19	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	4.35	8.98	4.35	5.17	3.54	3.81	0.00	0.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	8.43	5.34	1.12	1.12	1.41	1.12	0.28	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.51	5.08	0.21	1.48	0.63	0.42	1.48	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.08	2.72	1.91	1.36	0.54	0.82	0.27	0.27	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.44	1.76	0.88	0.44	0.00	0.88	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.13	2.04	1.63	0.82	0.82	2.86	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.55	3.11	2.33	1.16	0.39	3.49	0.00	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.96	6.26	1.66	1.66	2.21	0.74	0.00	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	8.37	4.65	0.93	1.16	0.23	0.00	0.70	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	9.32	5.44	1.29	1.04	0.00	0.78	0.52	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.64	2.92	0.88	1.17	0.58	0.58	0.29	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.39	0.93	0.93	0.46	0.00	0.00	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	21.80	7.40	2.47	2.88	0.82	0.41	0.00	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	10.74	17.80	2.76	0.92	1.84	0.00	0.00	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.59	14.51	0.85	1.71	1.71	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.69	12.13	1.21	1.52	0.61	0.91	0.61	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.37	16.85	1.44	1.20	2.17	0.96	0.72	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.71	7.57	0.67	0.67	0.67	0.45	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.35	5.34	1.00	0.33	0.33	0.33	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	0.00	0.00	1.86	0.00	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	5.65	1.51	0.38	0.00	0.00	0.75	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	2.18	0.87	2.62	0.00	0.00	1.31	0.00	0.44	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	1.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	9.42	1.41	0.71	0.47	0.47	0.47	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	10.70	4.34	0.93	0.62	1.24	0.62	0.16	0.62	0.16
adipose, donor1	10184-103D4	2.35	0.59	1.17	1.17	1.76	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	0.41	0.00	6.08	0.81	2.43	1.62	0.00	0.41	0.81
adipose, donor3	10186-103D6	1.63	3.54	2.45	2.18	2.45	0.00	0.54	1.09	1.36
adipose, donor4	10187-103D7	2.60	14.73	6.93	6.93	4.33	0.87	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1.26	1.26	1.58	1.10	0.95	3.16	0.47	0.63	8.68
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.14	5.47	0.93	2.67	2.13	1.60	0.27	0.67	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	29.30	8.58	1.07	1.43	1.43	0.71	1.79	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	4.41	1.16	0.70	0.46	0.00	0.00	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	2.70	4.73	1.35	1.35	0.34	0.34	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	0.88	0.88	0.59	0.29	0.29	0.00	0.00	0.00	0.59
amygdala - adult, donor10196	10167-103B5	2.37	4.74	3.56	4.74	1.19	1.19	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	5.27	3.45	1.01	1.42	1.22	0.61	0.41	1.42	0.81
amygdala, newborn, donor10223	10360-105E9	11.94	7.75	0.97	0.97	0.32	1.61	0.32	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	9.17	3.44	1.66	0.25	0.51	1.02	0.51	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.77	8.82	0.00	0.22	0.22	0.00	1.54	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.34	3.67	4.34	3.34	3.67	1.00	0.00	2.00	0.67
aorta, adult, pool1	10052-101G7	5.49	1.18	1.77	0.20	0.59	0.59	0.20	0.20	0.59
appendix, adult	10189-103D9	5.82	3.88	4.27	2.33	1.16	1.55	0.78	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	17.54	9.63	3.10	4.13	2.75	1.38	3.78	2.06
artery, adult	10190-103E1	10.87	1.36	1.36	0.00	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	68.52	37.23	7.39	3.33	3.91	5.65	1.88	3.62	2.17
b cell line:RPMI1788	10427-106D4	3.12	4.46	1.49	1.19	1.49	2.08	0.00	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.74	5.83	0.28	0.28	0.00	0.00	0.55	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	15.48	3.47	0.99	0.20	0.20	0.20	0.10	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	241.19	18.08	0.67	0.17	0.67	0.17	5.19	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.68	2.24	0.56	0.56	0.00	0.56	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	14.88	3.48	0.65	0.65	0.43	0.65	0.22	0.43	0.33
blood, adult, pool1	10053-101G8	13.29	4.43	4.43	0.00	0.00	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	4.28	0.00	0.00	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	19.57	2.02	2.70	0.00	0.67	1.35	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	1.03	1.03	2.05	4.10	4.10	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	3.23	5.01	2.12	2.23	1.67	0.45	0.11	1.22	1.00
brain, fetal, pool1	10085-102B4	0.00	2.67	0.00	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	1.65	1.65	0.99	0.66	0.33	0.00	0.00	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	8.36	4.12	1.50	1.12	1.12	0.50	0.00	0.37	0.37
breast, adult, donor1	10080-102A8	34.72	3.79	1.26	1.89	1.89	0.00	1.26	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	26.42	4.95	1.27	0.51	0.51	0.51	0.13	0.25	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	4.02	3.71	0.31	0.62	1.55	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.14	7.14	0.23	1.15	4.37	0.00	0.00	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.56	11.38	3.15	2.18	1.69	1.21	0.48	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	3.76	4.70	3.76	5.17	2.82	3.29	0.00	1.88	2.35
carcinoid cell line:NCI-H727	10735-110B6	5.14	3.83	2.19	0.66	0.55	0.98	0.22	0.66	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	1.58	3.80	2.85	1.90	1.27	3.49	0.00	1.58	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	2.13	3.19	5.32	5.06	3.73	2.13	0.00	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	8.06	3.45	2.30	2.30	1.15	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	5.86	5.86	3.51	2.01	1.67	0.33	0.00	1.17	1.17
caudate nucleus, adult, donor10258	10379-105H1	1.53	2.29	2.29	3.82	1.53	2.29	0.76	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.75	8.42	1.46	0.37	2.20	1.10	0.37	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	8.74	2.91	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	2.14	6.62	4.06	5.55	3.20	0.64	0.21	2.99	0.21
cerebellum, adult, pool1	10083-102B2	1.03	2.41	3.10	3.10	2.41	0.69	0.00	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	4.15	0.00	4.15	3.32	2.49	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	2.02	3.28	1.01	1.26	1.26	0.50	0.25	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	12.43	10.23	2.19	2.92	1.46	0.00	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	5.32	5.75	1.44	1.44	1.15	1.29	0.14	0.58	0.29
cervical cancer cell line:ME-180	10553-107I4	3.81	1.99	0.99	0.33	0.00	0.50	0.00	0.33	0.00
cervix, adult, pool1	10013-101C4	3.36	2.10	0.84	1.15	0.84	0.31	0.21	0.21	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	70.78	21.18	0.42	0.42	0.28	0.42	1.39	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	5.84	2.73	1.99	1.49	1.49	1.49	0.50	0.87	0.99
choriocarcinoma cell line:SCH	10785-110H2	5.91	5.79	1.72	1.11	2.22	1.23	0.00	0.62	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	9.96	5.46	2.37	0.95	1.66	3.08	0.47	0.71	1.66
chorionic membrane cells, donor1	12238-129G6	5.41	0.85	0.28	0.28	0.28	0.57	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	14.02	6.56	0.30	0.60	0.60	0.10	0.30	0.00	0.10
chorionic membrane cells, donor3	12240-129G8	1.10	0.55	1.10	1.10	0.00	0.55	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	6.06	1.01	4.04	2.02	6.06	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.37	3.27	0.38	1.15	0.38	0.77	0.77	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.71	8.87	2.53	1.27	0.21	0.84	1.27	1.06	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.40	3.34	0.00	0.00	0.00	0.26	1.54	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	44.51	3.14	0.24	0.00	0.00	0.00	1.21	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.14	4.07	0.00	0.41	0.00	0.41	1.22	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	117.49	5.89	0.00	0.00	0.00	0.00	3.83	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	31.54	3.65	0.52	0.78	1.04	0.52	1.04	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.80	24.69	1.60	1.37	2.74	0.23	0.46	1.37	2.29
clear cell carcinoma cell line:TEN	10636-108I6	11.45	3.64	0.69	0.35	1.39	0.17	0.00	0.87	0.69
colon carcinoma cell line:CACO-2	10513-107D9	2.75	1.46	0.92	0.92	0.73	0.92	0.37	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	1.14	3.80	0.38	1.90	2.66	1.14	0.00	0.38	0.76
colon, adult, donor1	10082-102B1	9.52	1.19	0.00	1.19	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	51.47	8.46	1.29	0.94	1.06	0.35	0.71	0.71	0.35
colon, fetal, donor1	10070-101I7	5.56	5.56	2.47	1.24	1.24	0.62	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	0.00	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.25	2.12	0.85	1.70	0.42	1.27	0.00	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1.81	0.91	2.11	0.75	0.60	2.72	0.15	0.30	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	1.83	1.41	1.41	0.71	1.69	1.97	0.42	0.14	0.42
corpus callosum, adult, pool1	10042-101F6	4.98	4.20	1.77	1.55	1.44	1.00	0.11	1.22	0.66
cruciate ligament, donor2	10295-104G7	29.18	4.05	0.00	0.00	1.62	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	2.41	0.80	0.00	0.00	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	2.64	4.56	1.68	2.16	0.48	0.72	0.00	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.46	1.38	2.07	1.84	0.23	2.98	0.23	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.70	10.77	0.77	1.54	0.77	0.77	0.26	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.44	8.43	0.24	0.72	0.24	0.72	0.24	0.48	0.48
ductus deferens, adult	10196-103E7	16.45	1.99	2.49	3.49	4.49	1.00	0.00	0.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	0.00	8.64	4.32	2.88	1.44	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.83	5.89	0.74	2.21	0.00	2.21	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	14.87	3.72	0.74	0.91	0.58	0.83	0.33	0.58	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.33	5.11	0.22	0.22	1.11	0.44	0.89	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	12.32	5.45	0.29	0.72	1.00	0.43	0.43	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	12.33	3.70	1.23	0.00	0.62	0.62	0.00	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	14.83	5.15	0.30	0.61	0.61	0.61	0.30	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.39	6.17	0.31	0.31	0.93	0.93	0.31	0.31	1.23
embryonic pancreas cell line:2C6	10603-108E9	11.82	5.25	0.00	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	106.26	10.73	2.01	0.00	0.34	0.00	3.35	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.65	8.88	1.63	1.63	1.81	0.91	0.18	0.91	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.29	21.71	1.93	1.29	1.29	1.13	1.77	0.96	0.80
epidermoid carcinoma cell line:A431	10426-106D3	47.35	14.56	2.00	0.44	0.78	1.11	0.11	0.33	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.14	8.03	1.76	0.88	0.55	1.32	0.66	0.66	0.66
epididymis, adult	10197-103E8	6.28	2.72	3.77	1.47	0.84	1.67	0.42	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.08	2.84	0.89	0.00	0.53	0.18	0.18	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	52.30	4.72	0.00	0.00	0.00	0.00	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	30.40	14.55	1.44	1.57	1.31	0.66	0.39	0.66	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.17	9.05	3.74	0.89	1.77	1.38	0.39	1.08	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.68	15.12	2.46	1.01	1.46	0.78	0.34	0.22	0.56
esophagus, adult, pool1	10015-101C6	9.34	2.55	0.85	0.21	0.74	0.64	0.21	0.64	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.01	2.88	3.63	0.88	1.13	3.63	0.50	1.63	2.50
eye - muscle inferior rectus, donor1	10272-104E2	12.07	4.83	0.00	2.41	2.41	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	10.52	2.10	2.10	4.21	0.00	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	5.95	4.46	4.46	1.49	1.49	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	16.05	5.73	3.44	0.00	4.59	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	11.66	5.83	1.46	0.00	0.00	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	3.81	2.29	3.05	0.76	1.02	1.02	0.00	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	20.39	5.13	0.26	0.26	0.38	1.03	1.03	0.26	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.34	10.45	0.24	0.24	0.47	0.47	1.42	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	4.03	5.44	3.28	4.03	1.88	0.66	0.00	1.03	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.31	5.70	2.10	3.30	1.50	1.50	0.30	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	148.77	18.74	0.64	0.37	0.18	0.37	2.19	0.37	0.27
gall bladder, adult	10198-103E9	12.31	3.14	2.17	2.17	1.69	1.45	0.00	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	2.68	9.66	7.52	5.91	2.68	4.29	0.00	2.68	0.54
gamma delta positive T cells, donor2	11938-126A3	6.35	8.59	2.99	2.24	1.49	1.49	0.75	0.75	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.54	8.87	0.00	0.84	1.06	0.21	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.51	0.58	1.55	0.77	0.77	0.77	0.00	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	10.49	6.89	1.80	1.80	1.80	0.82	0.33	1.97	0.49
gastric cancer cell line:GSS	10560-108A2	1.83	2.75	2.75	0.92	2.75	0.92	0.00	1.83	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.85	8.22	5.03	3.20	2.06	1.14	0.23	2.28	0.46
giant cell carcinoma cell line:LU65	10487-107B1	16.06	2.75	0.11	0.00	0.00	0.34	0.57	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	21.55	4.20	0.28	0.42	0.14	0.28	0.00	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.94	9.23	2.49	0.25	0.75	1.75	0.75	0.75	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.29	4.75	0.63	0.42	0.53	0.11	0.21	0.11	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.41	3.79	0.42	0.28	0.42	0.14	0.42	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	208.61	36.64	1.66	1.32	1.21	0.99	2.87	0.88	0.66
glioma cell line:GI-1	10413-106B8	6.44	3.51	0.59	0.59	0.29	0.29	1.17	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	5.10	4.37	0.00	5.83	0.00	0.73	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	8.30	5.61	2.44	2.93	1.95	0.24	0.24	1.46	0.49
globus pallidus, adult, donor10258	10367-105F7	0.00	1.37	2.74	0.00	1.37	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	26.11	10.66	2.13	1.60	2.13	2.13	0.53	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	0.00	4.89	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.72	4.80	0.64	0.32	0.32	0.32	0.64	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	4.59	5.05	3.67	1.38	0.46	1.84	0.46	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	4.57	5.03	0.91	0.91	0.00	1.37	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	3.22	3.22	0.64	0.00	1.29	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	0.00	4.31	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	3.43	3.43	0.69	0.69	0.69	0.69	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	1.10	1.10	0.00	1.10	1.10	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.29	1.15	1.15	0.29	2.30	0.29	0.00	1.44
heart - mitral valve, adult	10205-103F7	3.89	1.79	1.49	1.20	0.00	0.60	0.30	0.60	0.90
heart - pulmonic valve, adult	10206-103F8	2.88	1.57	2.09	0.26	1.05	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	9.16	0.00	0.83	0.00	0.00	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	11.84	5.51	2.24	1.02	1.63	0.41	0.00	0.20	1.22
heart, adult, diseased, donor1	10051-101G6	1.70	0.85	0.00	0.43	0.85	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	11.96	4.37	0.69	1.15	0.92	0.23	0.23	0.00	0.46
heart, fetal, pool1	10046-101G1	3.80	2.05	1.85	1.23	0.21	0.82	0.21	0.82	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.18	2.47	0.31	0.00	0.00	0.31	0.00	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	1.19	2.38	2.38	2.38	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	14.14	6.63	1.77	2.43	1.10	0.77	0.11	0.33	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	14.20	7.53	0.97	2.67	1.46	0.97	0.12	0.97	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	10.41	7.07	1.52	2.73	1.31	0.71	0.40	1.01	0.40
hepatoma cell line:Li-7	10484-107A7	93.87	9.45	0.11	0.11	0.44	0.11	2.89	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.32	8.24	1.41	3.62	2.81	1.31	0.10	0.50	0.30
hippocampus - adult, donor10196	10169-103B7	3.79	2.84	1.89	0.00	1.89	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	5.92	1.84	2.04	2.04	1.63	0.41	0.20	1.63	0.82
hippocampus, adult, donor10258	10374-105G5	0.00	1.99	1.49	1.49	3.49	1.00	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	18.68	7.05	3.17	0.70	0.70	1.41	1.06	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.66	2.44	0.00	1.83	0.61	1.22	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.91	3.53	1.96	1.18	2.16	1.77	1.18	0.98	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.09	3.55	0.25	1.02	0.51	3.05	0.51	0.51	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.00	0.56	2.82	0.56	1.13	1.69	0.56	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.29	0.52	0.52	2.32	2.32	0.52	0.26	0.52	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1.52	0.38	2.66	0.76	0.76	0.76	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	0.29	1.17	2.04	2.34	1.46	1.46	0.58	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.51	0.86	4.31	1.29	1.51	1.51	0.22	0.86	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.92	2.09	4.59	1.67	2.09	1.25	0.00	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1.42	1.66	1.66	1.18	0.71	0.47	0.00	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	3.21	1.61	2.57	2.25	1.45	2.41	0.16	0.48	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	2.02	1.35	1.35	0.00	2.02	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.10	3.76	0.94	1.56	0.78	2.03	0.63	0.16	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.42	1.47	0.00	1.47	2.46	0.49	1.47	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	3.49	0.87	0.87	0.00	3.49	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.95	0.76	1.72	1.72	3.05	1.15	0.00	0.57	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.87	0.00	2.18	1.74	0.87	0.87	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.00	1.00	1.50	1.50	3.00	1.00	0.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.00	0.75	2.07	1.13	0.75	0.94	0.00	0.38	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.45	0.91	4.09	2.27	1.82	0.00	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.31	1.25	3.45	0.94	1.25	1.25	0.00	1.88	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	0.98	0.82	1.14	1.31	1.31	0.65	0.00	1.14	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	0.87	1.74	2.32	0.29	1.45	0.58	0.00	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	0.60	1.79	3.89	1.20	0.30	0.90	0.00	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	3.69	2.40	1.29	2.03	1.66	3.33	1.29	1.48	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.71	3.99	1.71	2.57	1.14	2.00	0.86	0.29	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	3.67	5.72	2.86	2.04	2.04	1.22	0.82	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1.76	0.70	0.70	2.11	0.70	1.41	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1.27	1.27	2.22	2.22	1.58	1.58	0.63	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1.82	0.91	1.82	2.42	1.82	1.51	0.00	1.51	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	0.00	1.03	3.62	0.52	1.03	0.52	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	0.66	1.33	1.33	1.33	1.33	0.66	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1.54	1.54	4.10	0.77	0.26	0.51	0.26	0.26	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	2.05	0.77	2.30	1.28	1.02	1.28	0.00	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	3.03	1.51	3.03	1.51	1.51	2.27	0.00	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	2.35	0.67	4.03	2.02	0.67	1.01	0.00	0.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.59	1.93	0.97	0.72	2.90	3.62	0.24	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	3.12	2.23	1.78	1.78	1.34	2.23	0.89	0.45	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3.90	1.95	1.46	1.46	0.98	1.95	0.98	0.49	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.53	0.61	1.22	0.92	1.22	0.92	0.00	0.31	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	3.25	6.51	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.00	0.33	0.33	1.65	2.98	0.00	0.00	0.66	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	0.00	0.55	4.93	1.64	1.09	0.55	0.00	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1.81	1.45	2.53	0.72	0.36	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	0.71	2.14	1.07	0.36	1.07	0.36	0.00	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	0.00	4.77	3.58	1.19	2.39	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1.90	1.63	3.93	1.63	0.54	1.35	0.27	0.54	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	0.81	0.81	4.04	1.89	1.08	0.81	0.00	0.00	0.54
immature langerhans cells, donor1	11904-125F5	1.70	0.00	0.00	0.00	0.00	0.48	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	3.17	0.79	0.79	0.00	0.00	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	4.16	4.16	2.37	3.69	2.08	0.95	0.00	1.61	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	3.90	1.95	1.95	0.33	0.00	1.30	0.65	0.33	0.33
kidney, adult, pool1	10017-101C8	35.04	7.91	1.20	1.00	0.30	0.10	0.50	0.30	0.10
kidney, fetal, pool1	10045-101F9	15.56	3.61	1.41	0.57	1.06	0.92	0.28	0.14	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.52	2.70	0.99	0.57	0.28	0.00	0.00	0.43	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	48.38	9.54	0.41	0.41	0.69	0.41	0.14	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	26.79	8.07	2.02	0.37	0.73	2.02	0.37	0.92	1.47
left atrium, adult, donor1	10079-102A7	3.81	0.54	2.18	1.09	1.09	2.18	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.06	4.05	0.51	1.52	0.51	2.02	0.00	1.52	1.52
leiomyoblastoma cell line:G-402	10721-110A1	12.04	7.93	0.00	1.64	1.09	0.00	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	13.29	3.95	0.00	0.72	0.00	0.72	0.00	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	23.37	7.61	0.00	0.00	1.09	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	15.54	3.40	0.00	0.00	0.49	0.49	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	2.09	0.00	0.00	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	22.08	1.77	0.47	0.12	0.12	0.00	1.06	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	9.06	3.28	0.47	0.16	0.00	0.00	0.00	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	10.23	4.75	1.10	0.49	0.61	0.97	0.37	0.24	0.85
liver, adult, pool1	10018-101C9	39.38	12.48	0.16	1.30	1.46	0.49	0.97	1.30	0.16
liver, fetal, pool1	10086-102B5	62.09	35.75	0.94	1.88	0.00	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.65	6.12	2.04	2.19	1.17	1.17	0.15	1.60	0.73
locus coeruleus, adult, donor10252	10165-103B3	8.12	4.06	1.29	2.21	1.66	0.55	0.18	1.29	0.37
locus coeruleus, adult, donor10258	10375-105G6	6.77	7.90	1.97	3.39	1.69	0.85	0.00	1.69	1.41
locus coeruleus, newborn, donor10223	10362-105F2	24.40	17.67	2.52	1.26	2.52	0.42	1.26	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	115.97	10.38	0.00	0.28	0.14	0.14	4.84	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	81.35	6.20	0.69	0.69	2.07	0.69	3.45	0.00	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	10.41	2.64	1.58	0.13	0.53	0.53	0.26	0.26	0.00
lung, adult, pool1	10019-101D1	16.54	4.25	2.01	1.30	1.18	0.71	0.24	0.47	0.35
lung, fetal, donor1	10068-101I5	11.42	4.28	1.14	0.86	1.14	0.57	0.29	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	6.42	5.50	3.67	3.21	2.29	0.92	0.00	0.92	0.46
lymph node, adult, donor1	10077-102A5	5.68	3.31	5.68	1.42	1.42	1.89	0.00	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	0.44	1.97	1.10	1.32	1.97	1.75	0.22	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.75	1.81	2.72	1.51	1.21	1.51	0.15	1.36	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	10.19	5.95	0.85	0.00	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	56.39	17.76	0.44	2.22	2.22	0.44	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	48.35	9.34	0.42	1.25	1.04	0.00	0.83	0.42	0.21
mature adipocyte, donor3	12233-129G1	48.12	8.77	0.47	1.19	1.19	0.00	1.90	0.47	0.47
mature adipocyte, donor4	12234-129G2	37.11	11.06	0.79	1.32	0.79	0.00	1.58	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	49.08	7.86	5.48	3.10	2.14	2.38	1.19	2.86	6.67
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	5.64	1.13	9.02	1.13	2.26	1.13	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	6.99	6.44	3.31	1.84	1.29	0.92	0.18	1.29	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	2.86	2.22	2.86	4.13	0.32	1.59	0.00	3.49	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	13.65	5.54	2.56	0.85	1.28	0.43	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	5.57	6.41	2.53	2.19	1.52	1.52	0.17	1.86	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	4.67	6.15	1.70	1.91	1.70	0.21	0.00	1.27	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	5.78	1.93	0.00	0.00	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.87	7.90	1.44	2.15	0.36	0.72	1.08	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	13.63	5.19	2.60	3.24	1.30	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	6.66	5.11	2.32	0.77	1.24	0.31	0.31	2.17	0.77
medulla oblongata, adult, pool1	10038-101F2	7.10	5.80	1.80	1.80	2.20	1.06	0.24	1.22	0.49
medulla oblongata, newborn, donor10223	10361-105F1	20.14	5.90	5.21	2.08	0.69	0.69	1.04	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	4.87	4.43	2.66	2.88	3.32	1.99	0.00	1.33	0.22
medulloblastoma cell line:ONS-76	10759-110E3	15.04	9.90	0.73	0.61	1.10	0.61	0.12	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	3.31	1.29	1.15	0.29	0.72	1.29	0.14	0.29	1.01
melanoma cell line:G-361	10465-106H6	2.44	1.90	1.36	0.54	0.81	0.81	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	34.19	6.33	0.18	0.00	0.36	0.18	0.54	0.18	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.88	4.41	6.17	2.64	3.52	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.26	1.81	1.56	2.07	1.04	0.78	0.00	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.29	7.83	0.00	0.46	0.15	0.46	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.45	11.45	0.55	0.18	0.18	0.00	0.55	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	32.71	9.11	0.00	0.00	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.21	4.07	0.00	0.00	0.14	0.00	0.84	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	24.46	5.97	0.00	0.39	0.19	0.00	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	32.62	13.19	0.00	0.00	0.69	0.69	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	84.10	16.31	0.00	0.17	0.17	0.00	2.75	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	35.19	12.19	0.12	0.00	0.46	0.12	0.69	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.28	4.91	0.00	0.27	0.00	0.00	0.66	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	57.26	15.12	0.00	0.14	0.27	0.27	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	42.11	7.97	0.00	0.28	0.28	0.00	1.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.76	10.87	0.66	0.33	0.66	0.33	1.98	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.10	10.24	0.14	0.14	0.14	0.14	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.50	2.44	0.35	0.35	0.00	0.35	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.60	9.60	0.41	0.00	0.41	0.00	0.20	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	3.24	0.36	0.72	0.00	0.00	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.03	9.72	0.10	0.31	0.21	0.10	0.41	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.29	4.10	0.23	0.00	0.23	0.00	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	39.02	11.75	0.00	0.84	0.00	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.74	7.77	0.15	0.15	0.15	0.15	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	29.06	7.79	0.00	0.18	0.00	0.09	0.96	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	3.31	0.00	0.37	0.00	0.00	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.31	4.01	0.00	0.29	0.00	0.29	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	3.37	1.26	0.00	0.00	0.00	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	5.02	0.00	0.00	0.46	0.91	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.18	7.93	0.26	0.26	0.00	0.26	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.68	8.38	0.00	0.26	0.00	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.96	11.71	0.31	0.00	0.31	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.06	6.35	0.00	0.71	0.71	0.24	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.62	7.11	0.00	0.00	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	8.65	0.00	0.79	0.39	0.39	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.15	7.41	0.46	0.00	0.46	0.00	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	26.82	9.23	0.58	0.00	0.00	0.00	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.43	6.47	0.45	0.22	0.00	0.67	0.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.95	8.89	0.00	0.72	0.48	0.00	0.72	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.73	5.87	0.00	0.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.80	11.08	0.34	0.00	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.47	5.73	1.23	0.00	0.41	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.19	9.45	1.29	0.43	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	16.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.51	8.12	0.32	0.97	0.32	0.65	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	8.73	1.45	0.00	0.00	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	29.32	12.26	0.00	2.13	0.00	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	12.27	0.00	0.00	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.93	10.50	0.39	0.00	0.00	1.17	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	12.59	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	5.96	0.00	0.99	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	33.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	11.27	0.00	0.59	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	18.28	2.44	1.22	0.00	1.22	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	13.30	0.63	0.00	1.27	0.00	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.07	11.04	0.00	0.00	0.00	1.03	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	8.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	11.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	5.70	0.00	0.00	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	9.53	0.00	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.53	2.81	0.00	0.31	0.00	0.31	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	1.34	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	3.55	0.00	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	10.27	2.57	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.95	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	10.39	0.49	0.99	0.49	0.49	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	10.09	0.00	1.12	1.12	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	7.00	1.27	1.27	1.27	0.00	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.27	7.66	1.21	0.81	0.40	0.00	0.00	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	8.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	6.34	0.00	1.27	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	91.64	21.24	0.61	0.61	1.82	0.00	4.86	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	126.53	9.04	0.00	0.00	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	73.31	18.12	2.47	3.29	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	20.83	9.52	0.99	0.99	0.60	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	7.46	0.65	0.97	0.00	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	9.17	0.00	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	2.32	0.00	0.77	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.12	11.81	0.94	1.18	0.94	1.65	0.24	0.71	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	1.62	2.09	0.46	0.70	0.00	0.23	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.68	2.57	0.00	0.00	0.00	0.10	0.21	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	13.39	6.35	0.45	0.45	0.00	0.91	0.45	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	74.08	15.65	0.24	0.24	0.00	0.00	1.47	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	18.16	8.19	0.22	0.89	0.00	0.22	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	16.29	5.52	0.26	0.79	0.00	0.26	0.26	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	11.92	4.94	0.00	0.51	0.51	0.17	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	11.12	3.79	0.25	0.76	0.51	0.51	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	19.25	4.97	0.41	0.00	0.41	0.41	0.21	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	20.37	7.62	0.17	0.00	0.17	0.17	0.00	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	13.94	3.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	12.64	2.90	0.34	0.17	0.00	0.00	0.00	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	137.92	34.35	0.51	0.76	1.27	0.25	2.80	0.25	0.00
mesothelioma cell line:No36	10857-111G2	43.06	9.79	0.33	0.00	0.00	0.65	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	43.89	3.52	0.54	0.00	0.00	0.27	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	6.72	2.69	0.38	0.00	0.58	0.38	0.19	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	23.45	8.55	0.73	0.49	0.49	0.12	0.24	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	7.72	2.51	0.90	0.36	0.72	0.00	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.73	11.75	0.98	0.98	1.31	1.96	0.33	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	425.14	24.37	0.21	0.21	0.21	0.85	5.30	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.06	1.38	0.23	0.00	0.00	0.46	0.46	0.69	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.95	1.52	1.14	1.14	0.76	1.33	0.00	0.00	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	8.32	5.54	0.74	0.92	1.11	0.55	0.18	0.18	0.18
myeloma cell line:PCM6	10474-106I6	6.72	4.74	3.95	1.58	2.17	0.79	0.40	0.40	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.55	5.07	0.00	0.00	0.51	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	64.14	10.79	0.00	0.00	0.00	0.00	2.75	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.81	3.01	0.33	0.00	0.00	0.22	0.00	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.90	3.31	0.07	0.00	0.07	0.22	0.07	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	17.11	7.18	0.00	0.00	0.00	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1.38	0.92	1.38	1.15	1.15	0.46	0.00	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	4.49	5.43	0.75	3.93	1.87	0.56	0.00	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	1.69	0.84	2.74	3.37	2.53	2.11	0.21	1.27	0.63
neuroblastoma cell line:NH-12	10555-107I6	0.75	1.68	1.49	1.86	1.12	2.80	0.19	0.19	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.71	0.71	1.66	0.24	0.24	2.85	0.00	0.00	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1.11	1.90	1.11	1.43	1.11	0.95	0.00	0.63	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	0.20	0.40	1.21	1.61	1.01	1.81	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.27	1.27	0.00	1.27	0.00	0.64	0.00	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	18.10	3.46	1.06	0.00	0.53	0.80	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	163.62	29.75	29.75	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.01	2.71	1.69	3.38	1.18	0.85	0.17	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	130.48	12.81	0.00	0.00	0.80	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.31	8.02	0.64	0.96	0.96	0.00	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	97.75	48.35	1.31	0.53	1.58	0.79	1.58	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	3.09	3.75	2.72	2.62	1.03	0.66	0.00	1.69	0.37
occipital cortex - adult, donor10196	10172-103C1	4.12	10.30	2.06	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	8.86	3.22	1.61	2.95	1.34	1.34	0.54	1.34	0.81
occipital cortex, newborn, donor10223	10355-105E4	12.74	3.64	2.91	1.09	1.46	1.46	0.73	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	3.67	6.56	4.20	3.67	3.41	1.31	0.52	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	0.43	0.86	4.29	1.72	1.29	3.00	0.00	1.29	2.57
occipital pole, adult, pool1	10036-101E9	1.97	3.07	1.50	1.34	0.87	0.39	0.00	0.95	0.39
olfactory region, adult	10195-103E6	3.25	5.16	1.91	2.67	1.15	0.96	0.00	0.38	0.76
optic nerve, donor1	10277-104E7	8.00	6.00	2.00	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.99	8.09	0.68	0.46	0.68	0.00	0.57	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.96	7.42	1.37	0.96	0.82	1.24	0.00	0.41	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	13.04	4.06	1.35	1.19	0.68	1.69	0.68	0.85	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	19.98	4.16	0.69	0.35	0.69	0.35	0.23	0.46	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	20.58	5.00	1.18	0.29	0.88	0.29	0.59	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	24.29	3.74	0.00	0.00	0.00	0.00	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	3.61	3.82	0.64	1.91	0.42	0.85	0.00	0.21	0.85
ovary, adult, pool1	10020-101D2	5.94	1.57	1.31	1.22	0.61	0.44	0.17	0.70	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.58	3.67	0.18	0.18	0.00	0.00	1.47	0.00	0.00
pancreas, adult, donor1	10049-101G4	5.64	1.88	1.88	0.94	0.00	0.00	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.75	2.52	3.91	0.56	2.52	3.63	0.84	1.96	6.43
papillary adenocarcinoma cell line:8505C	10437-106E5	5.11	2.21	0.51	0.51	0.34	0.00	0.00	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.44	1.49	0.50	0.17	0.33	0.00	0.50	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	3.75	6.96	2.84	3.11	1.74	0.46	0.09	1.46	0.64
parietal cortex, adult, donor10258	10373-105G4	1.47	6.61	0.73	2.20	0.00	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	0.94	1.88	1.88	0.94	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	7.13	4.56	3.14	2.28	1.71	0.86	0.00	1.71	0.00
parietal lobe, adult, pool1	10034-101E7	3.88	4.32	2.64	3.35	0.79	1.23	0.00	1.67	0.44
parietal lobe, fetal, donor1	10072-101I9	1.94	0.00	5.82	0.97	2.91	1.94	0.00	0.00	3.88
parietal lobe, newborn, donor10223	10356-105E5	17.20	6.73	1.12	0.75	0.37	1.50	0.00	0.37	0.37
parotid gland, adult	10199-103F1	3.08	0.62	0.62	0.62	0.00	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	3.76	2.69	2.15	0.54	1.07	1.61	0.00	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	0.19	0.74	0.19	0.74	1.49	0.00	0.19	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.84	1.17	0.58	0.58	0.58	1.46	0.87	0.29	0.73
pineal gland - adult, donor10196	10179-103C8	0.65	1.94	1.94	1.29	0.00	0.65	0.00	2.58	1.29
pineal gland, adult, donor10252	10160-103A7	3.55	1.78	5.33	2.96	4.74	0.59	0.00	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	1.88	3.14	3.76	4.39	3.14	1.25	0.00	1.88	1.25
pituitary gland - adult, donor10196	10180-103C9	5.06	6.07	0.00	7.08	2.02	1.01	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	5.21	8.34	2.08	2.61	2.08	1.56	0.00	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	5.11	2.55	2.55	5.11	1.70	1.70	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	15.80	3.87	1.72	1.08	0.54	0.65	0.22	0.54	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	0.79	1.99	2.65	1.59	1.59	1.19	0.00	0.53	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	39.22	15.88	0.62	1.40	0.78	0.16	0.16	0.78	0.31
pons, adult, pool1	10033-101E6	8.86	5.94	1.81	4.13	1.55	0.26	0.60	1.72	0.34
postcentral gyrus, adult, pool1	10032-101E5	2.18	4.18	1.39	2.62	1.48	0.44	0.17	1.48	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	10.46	4.18	4.18	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	49.53	13.55	0.44	0.73	0.73	0.00	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	22.51	6.72	1.27	1.09	0.54	0.73	0.36	0.73	0.18
prostate, adult, pool1	10022-101D4	3.90	1.72	2.27	1.18	0.82	0.63	0.09	0.73	0.54
putamen, adult, donor10196	10176-103C5	3.78	4.96	2.83	2.12	2.36	1.65	0.00	1.89	1.18
putamen, adult, donor10252	10152-102I8	7.84	3.92	0.00	3.92	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	3.28	1.09	1.09	0.00	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.14	3.14	2.42	2.66	1.69	0.72	0.00	1.45	1.21
putamen, newborn, donor10223	10365-105F5	13.49	5.25	1.50	0.75	0.00	0.00	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	2.04	1.16	0.00	0.87	0.00	0.58	0.87	0.29	0.29
rectum, fetal, donor1	10067-101I4	2.78	0.00	2.78	1.39	0.00	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.65	10.81	0.21	0.85	0.21	0.00	1.06	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.98	5.38	0.83	0.41	0.83	0.41	0.41	1.24	0.83
retina, adult, pool1	10030-101E3	6.36	5.67	2.48	1.89	1.79	1.59	0.20	1.19	1.09
retinoblastoma cell line:Y79	10475-106I7	9.61	4.94	4.68	4.42	1.56	2.60	0.78	1.04	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	3.20	5.66	2.21	2.83	1.35	0.61	0.12	0.74	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1.97	1.41	1.41	0.84	0.84	0.56	0.00	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	61.39	15.91	0.00	0.76	0.00	0.76	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	9.55	3.40	0.49	0.16	0.16	0.16	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	1.93	1.65	1.38	0.55	0.41	0.28	0.14	0.14	0.14
salivary acinar cells, donor3	11773-123I9	1.32	0.66	0.00	0.66	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	4.00	1.14	2.86	0.00	0.00	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.95	2.53	0.42	0.08	0.17	0.17	0.34	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.76	2.23	0.12	0.12	0.12	0.47	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	8.99	4.23	1.06	1.59	2.65	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.03	7.04	0.24	0.97	0.49	0.00	0.00	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.33	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	3.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.36	9.40	2.01	1.21	0.54	0.67	0.67	0.81	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	11.94	4.53	0.66	1.22	0.44	0.33	0.44	0.11	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.64	2.58	0.52	0.13	0.13	0.13	1.55	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	0.00	1.42	1.42	0.00	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	19.79	7.08	1.32	0.72	1.80	0.36	0.12	1.32	0.36
skeletal muscle, fetal, donor1	10066-101I3	1.01	1.01	0.00	1.01	3.02	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	6.79	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	2.52	1.26	3.16	3.16	1.26	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.33	3.00	1.67	5.00	1.67	0.00	0.00	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	0.63	4.41	1.26	2.84	1.89	0.63	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	1.35	2.31	3.85	2.12	3.47	4.43	0.39	2.12	3.28
small cell lung carcinoma cell line:LK-2	10541-107H1	26.87	3.13	1.81	0.49	0.82	1.48	1.32	0.82	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.45	1.61	2.90	1.29	1.93	4.18	0.32	0.64	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	9.37	7.85	3.70	1.96	2.40	1.96	0.65	1.31	0.22
small intestine, adult, pool1	10024-101D6	49.57	8.12	1.07	0.96	0.96	0.60	1.07	0.84	0.36
small intestine, fetal, donor1	10064-101I1	4.42	2.95	1.47	0.98	1.23	0.98	0.25	0.25	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	55.91	5.64	0.51	1.03	0.00	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	3.62	2.58	0.52	0.26	0.26	0.26	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	16.35	3.22	0.80	0.27	0.27	0.27	0.54	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	7.80	5.74	2.52	2.75	1.61	1.15	0.23	1.15	1.61
spinal cord, adult, donor10252	10159-103A6	11.83	5.13	0.79	0.79	1.18	0.39	0.00	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	0.69	3.46	2.08	2.08	2.08	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	1.83	3.05	3.05	2.44	0.00	1.83	0.00	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	12.40	4.13	0.00	0.92	3.21	0.00	0.00	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.71	4.03	0.15	0.15	0.30	0.15	0.60	0.60	0.15
spleen, adult, pool1	10025-101D7	7.49	4.63	1.65	1.21	0.99	0.77	0.00	0.99	0.11
spleen, fetal, pool1	10044-101F8	11.44	1.99	2.38	1.03	1.35	0.64	0.08	0.56	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.41	0.83	0.93	0.41	0.41	0.00	0.21	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.06	8.73	1.14	0.57	0.00	0.95	1.33	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.76	15.03	1.75	2.80	1.05	1.40	0.70	0.35	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	86.33	15.31	0.45	0.68	0.45	0.45	0.34	0.23	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	255.01	46.17	0.00	1.27	0.00	0.42	2.97	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.85	7.62	0.85	0.85	0.42	0.42	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	2.14	1.07	2.14	0.00	0.00	0.00	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	1.14	1.71	1.14	0.00	1.14	0.57	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	10.59	6.44	1.25	1.04	1.45	0.21	0.00	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	2.59	3.10	1.03	1.55	1.03	0.52	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	15.54	7.77	0.71	2.12	0.00	0.71	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1.38	2.75	1.15	0.92	1.83	0.92	0.69	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	2.97	2.97	1.44	1.78	1.44	0.76	0.00	1.36	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.85	0.00	4.99	2.85	0.71	0.00	0.00	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1.32	0.88	3.52	0.00	1.32	0.44	0.00	2.20	0.44
tenocyte, donor1	11763-123H8	68.42	23.39	0.00	0.00	0.35	0.35	2.09	0.35	0.35
tenocyte, donor2	11765-123I1	85.08	23.65	0.00	0.76	0.38	0.00	2.67	0.00	0.76
tenocyte, donor3	11768-123I4	67.83	23.72	0.37	0.00	0.37	0.00	0.74	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	18.02	3.74	0.85	0.85	1.53	1.19	1.19	0.68	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	1.23	1.85	1.70	1.23	1.08	0.92	0.00	0.92	0.15
teratocarcinoma cell line:PA-1	10807-111A6	9.61	3.25	1.08	2.01	0.62	1.24	1.08	0.46	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.28	5.20	1.78	1.02	1.52	0.89	1.02	0.89	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.16	1.51	1.13	3.03	0.00	1.13	1.51	0.38	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	4.80	2.40	0.33	1.20	1.20	0.65	0.44	0.55	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.54	1.95	1.30	0.33	0.33	0.65	0.65	0.33	0.65
testis, adult, pool1	10026-101D8	4.62	2.25	3.65	1.40	0.86	1.07	0.11	1.18	0.43
testis, adult, pool2	10096-102C6	1.35	2.26	3.61	1.80	1.35	0.90	0.00	1.80	0.00
thalamus - adult, donor10196	10168-103B6	7.73	7.73	1.10	4.42	2.21	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	5.16	2.50	0.78	0.63	0.94	0.31	0.00	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	12.32	0.00	1.54	0.00	1.54	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	3.95	5.76	3.29	2.64	2.47	0.33	0.00	1.81	0.33
thalamus, newborn, donor10223	10366-105F6	18.41	8.05	1.15	1.15	1.15	1.15	0.00	1.73	1.73
throat, adult	10209-103G2	13.73	5.74	2.50	1.25	1.75	0.25	0.00	1.75	0.75
throat, fetal, donor1	10061-101H7	2.13	3.66	1.52	1.83	1.22	1.22	0.00	0.61	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	0.79	1.79	0.99	1.19	1.19	1.59	0.20	0.40	0.60
thymus, adult, pool1	10027-101D9	1.79	1.89	4.67	0.89	0.99	4.27	0.00	0.70	1.29
thymus, fetal, pool1	10043-101F7	3.01	2.18	3.74	1.14	0.52	1.25	0.00	0.52	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.05	4.79	0.53	0.53	0.40	0.13	0.80	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	10.76	4.33	0.84	0.84	0.84	0.14	0.00	0.42	0.42
thyroid, adult, pool1	10028-101E1	12.78	4.48	6.07	3.83	3.27	2.71	0.47	3.45	1.12
thyroid, fetal, donor1	10060-101H6	5.01	3.16	3.95	2.90	2.11	1.05	0.26	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	6.16	3.08	6.16	0.00	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	35.82	5.81	1.86	2.09	1.86	1.16	0.93	1.16	0.47
tongue, fetal, donor1	10059-101H5	2.36	1.18	3.55	0.79	1.18	0.00	0.00	0.00	0.79
tonsil, adult, pool1	10047-101G2	12.72	3.61	2.70	1.40	0.80	1.60	0.10	0.30	0.30
trachea, adult, pool1	10029-101E2	18.81	3.68	1.55	0.98	0.74	0.16	0.41	0.33	0.41
trachea, fetal, donor1	10058-101H4	6.92	1.54	1.54	1.15	1.15	1.54	0.00	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	79.00	22.67	0.00	0.00	0.71	0.35	2.13	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	11.04	2.13	0.81	0.30	0.30	0.71	0.20	0.51	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.19	9.71	1.41	1.57	1.10	1.25	0.47	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	22.83	0.00	1.90	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.37	3.81	0.76	0.34	0.51	0.42	0.34	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	2.09	4.17	0.00	0.00	2.09	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	2.22	1.37	1.54	1.02	0.68	1.19	0.00	0.17	0.00
uterus, fetal, donor1	10055-101H1	1.54	0.51	2.05	0.00	1.02	0.00	0.00	0.00	1.54
vagina, adult	10204-103F6	13.57	2.58	1.29	0.65	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	3.07	2.63	1.97	0.88	1.53	1.10	0.00	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.80	3.74	0.53	1.34	1.07	0.27	0.00	0.53	0.00